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ABSTRACT 
Inflammation is an important feature of several seemingly disparate neurological disorders, 
including multiple sclerosis, Parkinson’s disease and sepsis-related brain dysfunction. Inadequate 
oxygenation and mitochondrial dysfunction have been implicated in these and other CNS 
pathologies in which inflammation is found. Indeed, inflammation can have direct or indirect effects 
on mitochondrial function, for example, via reactive oxygen/nitrogen species, or through 
compromised perfusion respectively. However, the study of oxygenation and mitochondrial 
function in the CNS has been limited as tissues are typically excised for study in vitro, invariably 
exposing cells and their mitochondria to non-physiological environments. To overcome these 
limitations, the work described in this thesis involved the study of mitochondrial dysfunction and 
tissue oxygenation in the CNS during local and systemic inflammation in whole-animal 
preparations under physiological and pathophysiological conditions. 
The experiments include development of in vivo optical imaging techniques to assess the 
redox potential of mitochondria, without the application of dyes, and with an intact blood supply. 
Using this technique in conjunction with established methods we investigated mitochondrial 
function and tissue oxygen concentrations in cortical and retinal models of local and systemic 
inflammation.  
Our findings reveal that mitochondrial flavoprotein autofluorescence imaged in the cortex 
of anaesthetised mice can be used to assess an aspect of mitochondrial function (redox potential) in 
the CNS in vivo. Additionally, we show that certain types of inflammation are associated with tissue 
hypoxia in the brain and retina, and that this can have profound functional consequences for cerebral 
mitochondria during systemic inflammation. Hypothermia was also explored as a potential 
therapeutic strategy to attenuate inflammation-induced functional deficits. 
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Collectively, these findings further our understanding of the mechanisms underlying 
neurological deficits associated with inflammation, and reveal mitochondrial redox state 
imbalances in certain inflammatory conditions with potential implications for the treatment of CNS 
disorders in which inflammation plays a role. 
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CHAPTER ONE 
1. Introduction 
1.1. Inflammation 
Inflammation is an adaptive mechanism aimed at limiting tissue damage by, for example, 
preventing the spread of infiltrating pathogens, and promoting recovery. However, chronic or 
excessive inflammation can lead to large scale damage. Despite the ‘immune privilege’ enjoyed by 
the central nervous system (CNS), including a blood brain/retinal/spinal cord barrier and the 
absence of a conventional lymphatic system, it is now appreciated that inflammation plays a key 
role in many physiological and pathological processes in the CNS (Carson et al. 2006; Galea et al. 
2007). As such, CNS inflammation has been associated with several neurological conditions, 
including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS) and sepsis-related 
brain dysfunction (Akiyama 2000; Bennett and Stuve 2009; Mcgeer and Mcgeer 2004; Trapp et al. 
1998; Young et al. 1990). Additionally, inflammation has been implicated in ocular pathology of 
various types, such as uveitis (which can occur for example in MS, juvenile rheumatoid arthritis or 
inflammatory bowel disease) or age-related macular degeneration (AMD) (Calabresi et al. 2010; 
Coffey et al. 2007; Flemming 2011; Hageman et al. 2005; Hollyfield et al. 2008). Therefore, the 
study of the consequences of CNS inflammation remains an important topic and both the effect of 
local inflammation, as well as peripheral inflammation on CNS organs, is of great importance.  
A large body of evidence now implicates the failure of bioenergetics in inflammatory 
pathology, including both mitochondrial damage leading to dysfunctional oxygen uptake, as well 
as vascular complications which result in inadequate oxygen delivery and secondary mitochondrial 
dysfunction. 
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Inflammation in the CNS involves several characteristic changes, including the activation 
of resident immune cells, such as microglia, and the recruitment of other immune cells, including 
macrophages and/or lymphocytes. Inflammation often also involves the production of reactive 
oxygen and nitrogen species such as superoxide and nitric oxide (NO) as well as changes in the 
vasculature, such as increased permeability or disturbed blood-flow. 
Microglial activation is characteristic of CNS inflammation (Kreutzberg 1996) and is an 
early indicator of inflammation (Banati et al. 1993; Gehrmann et al. 1995; Kreutzberg 1996). 
Microglial/macrophage activation, following trauma or pathogen entry, involves their proliferation 
and migration towards the pathological stimulus (Kreutzberg 1996) as well as an upregulation of 
major histocompatibility complexes (MHC) and enhanced phagocytic activity (Kreutzberg 1996). 
Their activation can be assessed by morphological changes (Nakajima and Kohsaka 2005; Streit 
2005) or by the expression of certain markers including CD68. Microglia and macrophages, as well 
as other activated cells, including endothelial cells (Kroll and Waltenberger 1998; Nussler and 
Billiar 1993), can then produce reactive nitrogen and oxygen species as well as a host of 
inflammatory cytokines and chemokines (Banati et al. 1993; Gibson et al. 2005) which amplify the 
immune response by recruiting other immune cells to the site of injury. Such responses are primarily 
aimed at pathogen destruction but can be associated with host tissue damage (Bennett and Stuve 
2009; Block and Hong 2005), including damage to mitochondria and the vasculature. Oxidative 
stress is particularly important in situations of inadequate antioxidant defences, such as occur in 
several inflammatory conditions (Goode et al. 1995; LihBrody et al. 1996; Spronk et al. 2005). 
Under such circumstances, reactive oxygen species can more readily result in DNA damage and 
lipid peroxidation, including in both mitochondria (Richter et al. 1988; Shigenaga et al. 1994; Yakes 
and VanHouten 1997) and endothelial cells (Spronk et al. 2005). Such damage can be particularly 
important in mitochondria which are themselves a major source of free radicals when leaking 
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electrons from the electron transport chain (ETC) to reduce oxygen into superoxide anions (Boveris 
and Chance 1973; Murphy 2009; Turrens 1997; Turrens 2003).  
Inflammation can also lead to an up-regulation of inducible NO synthase (iNOS) (Bruins 
et al. 2002; Sato et al. 1995; Wong et al. 1996), which can produce high levels of NO in many cell 
types, including inflammatory cells and endothelial cells (Nussler and Billiar 1993). NO can be a 
potent reversible as well as irreversible inhibitor of mitochondrial function (see below: 
‘Mitochondria in inflammation’) and also plays an important role in physiological and pathological 
regulation of the vascular network. Under physiological conditions NO (including NO produced by 
endothelial NOS (eNOS)) can influence vasodilation and blood flow in response to a variety of 
stimuli (Dirnagl et al. 1993; Lowenstein et al. 1994; Minson et al. 2001; Palmer et al. 1987; Vallance 
et al. 1989). Additionally, pathological up-regulation of iNOS can reduce vascular resistance and 
vascular reactivity to changes in oxygen supply/demand, and can reduce vascular contraction in 
response to agents such as noradrenaline (da Silva-Santos et al. 2002; Fernandes and Assreuy 2008; 
Fleming et al. 1991). Despite the extensive body of research implicating NO in inflammatory 
damage, a randomized controlled phase III trial on the effect of N-monomethyl-L-arginine (L-
NMMA; non-specific NOS inhibitor) in septic patients had to be prematurely terminated due to 
higher mortality in the treatment group (Grover et al. 1999). Thus, the 28-day mortality rate in the 
treatment group was 10% higher compared to the placebo group. This effect could be attributed to 
NOs role as a competitor to oxygen for the binding site on complex IV. This competition with O2 
has been suggested to regulate mitochondrial respiration in response to changes in available oxygen, 
allowing mitochondria to sense oxygen changes effectively (Brown 1995). Such a regulation of 
oxygen consumption could prove beneficial in situations of reduced oxygen supply. Therefore, even 
if NO inhibition improves oxygen delivery in sepsis through improved haemodynamics, the 
beneficial effects might be counteracted by increased oxygen consumption, which is in line with 
findings suggesting increased oxygen consumption during inhibition of NOS (Laycock et al. 1998; 
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Shen et al. 1994). This would suggest that respiratory inhibition might prove beneficial in 
inflammatory conditions in which oxygenation is compromised (see chapter 3). 
Additionally, other inflammatory mediators can influence vascular function during 
inflammation. Examples include neutrophil and/or cytokine-mediated endothelial cell damage 
(Fujita et al. 1991; Meyrick et al. 1991), up-regulation of adhesion molecule expression (Astiz et 
al. 1995; Smith 1993), a decrease in red blood cell deformability (Astiz et al. 1995; Machiedo et al. 
1989; Powell et al. 1991; Todd et al. 1993), an increase in vascular permeability (Wedmore and 
Williams 1981), coagulation (Schouten et al. 2008) and vascular flow heterogeneity (De Backer et 
al. 2002). All these factors have potential to influence organ perfusion and it is therefore not 
surprising that inflammation has been associated with tissue hypoxia (Eltzschig and Carmeliet 
2011; Karhausen et al. 2005), including in animal models of MS (Davies et al. 2013) and sepsis 
(Goldman et al. 2004; Ince 2005; Vallet et al. 1994). Indeed, deficiencies in motor function 
associated with the clinical onset of experimental autoimmune encephalomyelitis (EAE, a rodent 
model of MS) were attenuated by oxygen therapy (Davies et al. 2013) and treatment aimed at 
microcirculatory recovery in sepsis have shown promise (Anning et al. 1999; Bateman and Walley 
2005; Spronk et al. 2002). However, limited information exists on the spatial distribution of hypoxia 
during inflammatory diseases. 
1.1.1. Inflammation in sepsis 
During conditions of severe infection, the associated pathogen may enter the bloodstream 
and cause a whole-body inflammatory response which can result in systemic inflammatory response 
syndrome and sepsis. Sepsis is therefore an often fatal condition of systemic inflammation, 
occurring distal from the original insult. Sepsis can lead to its hallmark multiple organ dysfunction 
and eventually death by combined damage from the invading pathogen and, more importantly, from 
the over-activity of the host immune system (Cohen 2002; Schouten et al. 2008). During the initial 
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infection pathogenic components, such as lipopolysaccharides (LPS, or endotoxin) from the cell 
wall of Gram-negative bacteria, can result in the activation of immune and endothelial cells via 
pattern recognition receptors, including toll-like receptor 4 (TLR4) (Chow et al. 1999; Henneke and 
Golenbock 2002). Complex inflammatory cascades follow which can influence both mitochondrial 
and endothelial cells resulting in, for example, mitochondrial swelling (Crouser et al. 2002a; 
Crouser et al. 2002b; Zapelini et al. 2008), cytochrome c release (Zapelini et al. 2008), 
mitochondrial depolarisation (Lowes et al. 2008), dysfunctional energy production (Brown and Bal-
Price 2003; Chaudry et al. 1979; Leist et al. 1999) as well as endothelial cell damage and apoptosis 
(Frey and Finlay 1998), enhanced adhesion molecule expression (Albelda et al. 1994; Parent and 
Eichacker 1999), increased vascular permeability (Pickkers et al. 2005; Wilhelm 1962), 
hypovolaemia (Wilson et al. 1971) and hypotension (Kumar et al. 2006) which provide the 
hallmarks of sepsis-related dysfunction. LPS are very important molecules in sepsis, as ~45% of 
sepsis cases are caused by Gram-negative bacteria (Alberti et al. 2002) and even the more severe 
toxic shock sepsis, associated with an initial Gram-positive bacterial infection (typically seen in 
women after prolonged retention of tampons or intrauterine devices), has been associated with 
hypersensitivity towards LPS (Cohen 2002). After binding to the TLR4 (Chow et al. 1999), LPS 
induced a strong inflammatory reaction mediated for example by the rapid expression of tumour 
necrosis factor α (TNF-α) and interleukin-1 (IL-1). TNF-α and IL-1 are then able to affect the 
transcription and translation of numerous other inflammatory mediators, including iNOS (Dinarello 
1997) which produces NO and thereby affects both the vasculature and the local tissue environment, 
including mitochondria as mentioned before. During or following a period of intense inflammation, 
compensatory anti-inflammatory activity can be initiated, including the production of interleukin-
10 (Marchant et al. 1994) and transforming growth factor-β (Marie et al. 1996). This compensatory 
anti-inflammatory reaction has been suggested to be an adaptive response to limit the spread of 
immune-mediated damage but which can also play a detrimental role in the pathogenesis of multiple 
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organ dysfunction and death, leaving some patients immune-suppressed and unable to combat 
infection (for reviews see (Adib-Conquy and Cavaillon 2009; Bone et al. 1997)).  
Although comparatively understudied it is now clear that the brain plays an essential role 
in the disease course of sepsis. In fact studies have shown that brain dysfunction, including delirium, 
confusion and even coma, occurs in around 70% of patients (Young et al. 1990), is associated with 
increased mortality (Eidelman et al. 1996; Sprung et al. 1988) and can result in prolonged cognitive 
impairment in survivors of sepsis (Semmler et al. 2013). Such symptoms can occur even in the 
absence of local CNS inflammation (Sonneville et al. 2013) and instead systemic inflammation can 
be relayed to the brain via the vagus nerve and/or circumventricular organs (Sonneville et al. 2013). 
These pathways can then lead to an increase in the transcription of several inflammatory mediators 
and to microglial cell activation (Hannestad et al. 2012; Semmler et al. 2005). In addition, vascular 
changes have been observed also in cerebral structures, including endothelial cell dysfunction 
(Handa et al. 2008), altered cerebral perfusion (Bowton et al. 1989; Maekawa et al. 1991) and 
vascular autoregulation (Taccone et al. 2010), swelling of perivascular astrocytes (Papadopoulos et 
al. 1999), blood brain barrier breakdown (Jeppsson et al. 1981; Young et al. 1992) and oedema 
(Papadopoulos et al. 1999), suggesting an additional, more direct pathway for brain damage in 
sepsis. Indeed, in a porcine faecal peritonitis model, brain damage was evident not only in terms of 
vascular abnormalities and oedema, but also in terms of neuronal shrinkage, and darkening of 
neurons as assessed by electron microscopy, 8 hours after the induction of peritonitis (Papadopoulos 
et al. 1999). The authors suggest that these alterations stem from early neuronal degeneration and 
point out that more prolonged disease, as seen in patients, is likely to result in greater damage 
(Papadopoulos et al. 1999). Other models of sepsis have also resulted in neuronal damage and 
apoptosis, including systemic LPS in rodents (Semmler et al. 2005). Here the authors report 
activation of glia (astrocytes and microglia), up-regulation of iNOS and neuronal apoptosis. 
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Neuronal apoptosis was attenuated by administration of L-NMMA, a non-specific nitric oxide 
synthase inhibitor (Semmler et al. 2005).  
In summary, it is clear that the immune system plays an essential role in the development 
of sepsis, and sepsis-related multiple organ dysfunction, and that LPS is commonly a prime 
mediator of this inflammatory reaction. Additionally, the brain is not spared from inflammatory 
damage during sepsis and can significantly affect the survival of the septic patient. Therefore the 
study of the effect of systemic LPS on the brain is important to aid the understanding of the 
pathogenesis of sepsis and its sequelae. 
1.1.2. Inflammation in the retina 
Ocular inflammation is associated with numerous diseases including MS (Zein et al. 2004), 
juvenile rheumatoid arthritis (Anesi and Foster 2012; Wolf et al. 1987), inflammatory bowel disease 
(Orchard et al. 2002), Reiter’s syndrome (Kiss et al. 2003) and others (Kongyai et al. 2012; Rothova 
et al. 1992). As such it is considered to be the most common form of ocular inflammation, 
responsible for 10% of visual impairments in the western world (Nussenblatt 1990). Uveitis can be 
caused both by external infectious agents entering the eye (i.e. exogenous inflammation), or through 
endogenous mechanisms if no infectious agent is involved (Forrester 1991). The latter type has 
been associated with autoimmunity, including immunity against inter-retinal binding protein and 
retinal soluble antigen (Desmet et al. 1990; Fukushima et al. 1997; Gupta et al. 1996; Matsuo et al. 
1986; Nussenblatt et al. 1980; Selmi 2014). Uveitis can influence the anterior portions of the eye 
(e.g. iris and ciliary bodies of the eye) and/or the posterior segments, including the retina. The work 
presented here will focus only on retinal inflammation. 
Inflammatory infiltrates in the eye can cause loss of vision directly by clouding of the ocular 
compartments, or indirectly through pathological effects on aqueous fluid dynamics (Forrester 
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1991). Additionally, more severe damage is associated with inflammatory oedema and macular 
damage, as well as neovascularisation which can significantly impair vision (Forrester 1991). 
Numerous immune cell types have been implicated in uveitis, with neutrophils characteristically 
involved in early acute stages of uveitis, lymphocytes driving chronic inflammation, activated 
macrophages/microglia providing both antigen presenting and phagocytic roles and endothelial 
cells together with glial cells contributing important resident immune functions (Chan et al. 1987; 
Chan and Li 1998; Deschenes et al. 1988). 
As with systemic inflammation, the vasculature of the retina is not spared from the effects 
of ocular inflammation. Indeed, in a mouse model of posterior uveitis the infiltration of 
inflammatory cells (including lymphocytes and macrophages) into the retina was preceded by a 
breakdown of the blood-retinal barrier and endothelial expression of adhesion molecules, including 
intercellular adhesion molecule 1 and p-selectin (Xu et al. 2003). Additionally the number of non-
perfused vessels was increased and morphological changes in the vasculature were observed, 
including straightening of naturally curved vessels (Xu et al. 2003). The vascular pathology 
occurring during retinal inflammation has been attributed to the activity of inflammatory cytokines, 
including vascular endothelial growth factor (VEGF), TNF-α and IL-1β, as well as NO, which are 
capable of activating endothelial cells, opening tight junctions and recruiting and activating other 
immune cells (Bamforth et al. 1996; Carmo et al. 2000; Claudio et al. 1994; Leal et al. 2007; Luna 
et al. 1997). Together, these factors are capable of causing blood retinal barrier breakdown as well 
as immune cell infiltration. Such effects on the retinal vasculature, together with the occurrence of 
inflammation-associated oedema (Kapin et al. 2003) and increased intraocular pressure (Panek et 
al. 1990), which can lead to vascular compression, can conceivably result in tissue hypoxia. Indeed, 
ocular inflammation has been associated with neovascularisation (Graham et al. 1987; Shorb et al. 
1976), suggesting inadequate oxygen concentrations in the inflamed retina. Therefore, the 
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relationship between different types of retinal inflammation and tissue hypoxia remain important, 
especially given the retina’s inherent vulnerability towards hypoxia (see chapter 4). 
1.1.2.1. Ocular inflammation in multiple sclerosis 
MS is a neurodegenerative and demyelinating disease of the CNS (Dutta et al. 2006; Qi et 
al. 2007) which typically takes an initially relapse/remitting disease course (with symptomatic 
phases being alleviated by symptomless periods) followed by incomplete recovery and eventually 
gradual, progressive degeneration (Maurer and Rieckmann 2000). A subset of patients will instead 
develop primary progressive MS which omits the relapse-remitting phase and is a continuous, 
progressive degenerative disorder (Thompson et al. 1997). Symptoms include weakness, 
depression, fatigue, cognitive impairment, paralysis and visual loss (Chwastiak et al. 2002). Visual 
defects are often the earliest disease manifestation (Leibowitz and Alter 1968) and are in fact 
common throughout the disease, being expressed by 80% of MS patients (Fisher et al 2006). 
Additionally, it has been reported that most MS patients show pathology in the optic nerve tract 
(Mogensen 1990; Toussaint et al. 1983; Ulrich and Groebkelorenz 1983).  
Although most work on optic pathology in MS focusses on myelin containing structures, 
such as the optic nerves, some observations have also been made in retinal MS pathology. These 
advances have been accelerated by the development of clinical techniques for the assessment of 
retinal damage in MS patients, including optical coherence tomography, which noninvasively 
provides cross-sectional images of retinal morphology (Huang et al. 1991). Such techniques have 
revealed thinning of the nerve fibre layer and macular (Henderson et al. 2008; Toledo et al. 2008; 
Trip et al. 2005) even in eyes without a history of optic neuritis (Fisher et al. 2006). The latter 
finding suggests that not all MS-related retinal atrophy may originate in the optic nerve, but that 
primary retinal damage may be important. And indeed, despite an absence of myelin, retinal 
inflammation occurs in a subset of MS patients (Biousse et al. 1999; Graham et al. 1989; Green et 
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al. 2010; Kerrison et al. 1994; Le Scanff et al. 2008). A histochemical assessment of a large number 
of patients’ samples showed enhanced nerve fibre and ganglion cell layer loss in keeping with 
previous reports (Henderson et al. 2008; Toledo et al. 2008; Trip et al. 2005), but also an additional 
atrophy of the inner nuclear layers which is composed mainly of bipolar, horizontal and amacrine 
cells (Green et al. 2010). They also reported the presence of retinal inflammation, which was 
predominantly found in relapsing-remitting MS (29%), with fewer (5%) primary progressive MS 
patients exhibiting retinal inflammation (Green et al. 2010). Additionally, gliosis was noted together 
with some vascular abnormalities, including thickening of vessel walls (Green et al. 2010), retinal 
phlebitis (inflammation of the veins and surrounding tissues) (Kerrison et al. 1994), and increased 
retinal vascular permeability in optic neuritis patients which was predictive of a later diagnosis of 
MS (Lightman et al. 1987). 
Authors Year Findings 
Henderson et al 2008 
Thinning of the nerve fibre layer and macula Toledo et al 2008 
Trip et al 2005 
Fisher et al 2006 
Thinning of the nerve fibre layer and macula even in eyes 
without a history of optic neuritis 
Biousse et al 1999 
Retinal inflammation in a subset of patients 
Graham et al 189 
Green et al 2010 
Kerrison et al 1994 
Le Scanff et al 2008 
Green et al 2010 
Atrophy of the inner nuclear layers, gliosis and vascular 
abnormalities, including thickening of vessel wall 
Kerrison et al 1994 Retinal phlebitis 
Lightman et al  1987 
Increased retinal vascular permeability in optic neuritis 
patients, predictive of a later diagnosis of MS 
Table 1.1.2.1.1. Summary of retinal findings in MS 
27 
 
1.1.2.2. Inflammation in the aged eye 
Inflammation has been extensively implicated in normal ageing (Chung et al. 2006; Chung 
et al. 2009; Harman 1956). It has been stated that an altered redox state, characterised by an up-
regulation of reactive oxygen and nitrogen species and loss of antioxidant defences, occurs in 
normal ageing (Chung et al. 2006; Chung et al. 2009). Such reports have led to the development of 
the molecular “Inflammation Hypothesis of Ageing” (Chung et al. 2006). This theory suggests that 
continuous low-level inflammation during ageing could provide the bridging link between normal 
ageing and age-related diseases. This is founded on several reports of increased inflammatory 
mediators in aged tissues, including increased cyclooxygenase-2 gene expression in the aged kidney 
(Kim et al. 2000), upregulation of eNOS and iNOS in vessel walls (Cernadas et al. 1998), an 
augmented iNOS expression and NO production in response to LPS (Chorinchath et al. 1996; 
Poynter and Daynes 1999), enhanced cytokine secretion by T cells (Hobbs et al. 1993; Riancho et 
al. 1994; Roubenoff et al. 1998), and increased nuclear factor-κB DNA-binding (Helenius et al. 
1996; Korhonen et al. 1997). The link between ageing and inflammation is further supported by 
evidence of an attenuation of this age-related inflammation by factors known to increase longevity, 
including calorific restriction and exercise (Chung et al. 2009). Other theories, including the free 
radical theory of ageing (Harman 1956), have also implicated inflammation, particularly free radical 
generation, in normal ageing and age-related diseases. This theory also highlights the importance 
of a balance of pro- and anti-oxidant systems which may be derailed in ageing and age-related 
diseases (Chung et al. 2009; Harman 1992). Again, despite a loss of antioxidant defences with age, 
interventions, including calorific restriction and exercise, can attenuate this imbalance (Carter et al. 
2007; Cho et al. 2003) supporting the suggestions of a link between inflammation and physiological 
ageing. 
The retina is not spared from age-associated inflammation. A study employing fundus 
autofluorescence in young and aged mice revealed an increase in the number of retinal microglia 
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with age (Xu et al. 2008). This finding is complemented by observations of enhanced microglial 
activation in the aged retina, as assessed by MHC class II and ED1 labelling, suggesting increased 
antigen presenting and phagocytic capacity (Chan-Ling et al. 2007). The same study also reported 
a significant increase in blood-retinal barrier breakdown (as assessed by leakage of intravascular 
tracers and occludin expression) and altered vascular morphology in agreement with previous 
observations (Hughes et al. 2006). This previous study detected structural vascular changes using 
flat-mount histochemistry, which included broadening of veins and capillaries, as well as thickening 
of their basement membrane, increased vessel tortuosity and kinking as well as the formation of 
arteriovenous shunts (Hughes et al. 2006). Additionally, increased vessel blockage was observed in 
the peripheral retina together with increases in vascular loops and spirals which were suggested to 
indicate angiogenesis (Hughes et al. 2006). The authors of this study argue that some of the changes 
observed, including the thickening of the basement membrane and altered expression of calponin 
(a calcium regulating protein), lead to impaired vascular autoregulation as well as reduced nutrient 
and oxygen exchange across the vessel walls (Hughes et al. 2006). These factors were suggested to 
result in ‘physiological hypoxia’ in the aged retina which in turn explains the putative compensatory 
angiogenesis observed (Hughes et al. 2006). 
Another study found increased amyloid beta deposition in aged retinal vessels and around 
Bruch’s membrane which was suggested to negatively affect retinal perfusion (Kam et al. 2010). 
Such deposits of amyloid β are expected to increase immune cell activation (Akiyama et al. 2000; 
Davis et al. 1992; Giovannini et al. 2002; Kam et al. 2010; Meda et al. 1995a; Meda et al. 1995b), 
leading to an age-related increase in retinal inflammation together with compromised perfusion. 
Inflammation has additionally been implicated in the formation of age-related drusen, the 
hallmark of age-related macular degeneration (AMD) (Anderson et al. 2002). AMD is the leading 
cause of blindness in the over 50s in the western world (Bressler et al. 1988) and is characterised 
by the presence of druses, choroidal neovascularisation, atrophy of the retinal pigment epithelium 
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(RPE) and visual loss (Bressler et al. 1988). Drusen are hydrophobic deposits, which include 
lipoproteins as well as pro-inflammatory components (Englander and Singh 2013), and are located 
between Bruch's membrane and the RPE (Strauss 2005). While dry AMD is primarily charcterised 
by such drusen deposits, wet or exudative AMD includes neovascularisation of the choroid with 
infiltration of vessels into the outer retina, which is normally avascular (Nowak 2006). Post-mortem 
assessment of drusen shows a clear link between drusen and inflammation through, for example, 
enhanced presence of components of the complement cascade, including C3, C5 and the membrane 
attack complex (Anderson et al. 2002). The complement cascade is further implicated in AMD as 
single-nucleotide substitutions of the complement factor H gene (a regulator of the alternative 
pathway of the complement system; for more detail see chapter 4) are commmon in AMD patients 
(Coffey et al. 2007; von Leithner et al. 2009) and a mouse knockout results in visual deficit and a 
phenotype similar to human AMD (Coffey et al. 2007).   
1.1.3. Mitochondria in inflammation 
Mitochondria are essential organelles, involved in adenosine triphosphate (ATP) 
production, calcium buffering, apoptosis and redox signalling. As such, damage to mitochondria 
has been associated with several neurodegenerative diseases including MS (Erecinska and Silver 
2001;  Mahad et al. 2008), Parkinson’s disease (Schapira et al. 1998), sepsis (Fink 2002a) as well 
as others (DiMauro and Schon 2003; DiMauro and Schon 2008; Kang and Hamasaki 2005). 
Inflammation is known to have a significant damaging effect on mitochondrial function as several 
inflammatory mediators are capable of inducing mitochondrial dysfunction, including reactive 
oxygen and nitrogen species. Nitric oxide, for example, is capable of reversibly inhibiting 
mitochondrial function through competition with oxygen for binding to cytochrome c oxidase 
(Brown 2001; Brown and Cooper 1994; Cassina and Radi 1996; Cleeter et al. 1994; Schweizer and 
Richter 1994). Prolonged exposure to NO, or its reactive derivatives (reactive nitrogen species), 
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can also irreversibly inhibit mitochondrial function through several mechanisms, including the 
inhibition of mitochondrial complexes (Clementi et al. 1998), the induction of proton leak (Brookes 
et al. 1998) and/or the initiation of mitochondrial permeability transition and apoptosis (Hortelano 
et al. 1997). The combination of NO and superoxide can cause additional damage via the highly 
reactive intermediate peroxynitrite (Bolanos et al. 1995). Mitochondria are believed to be 
particularly susceptive to oxidizing agents as they themselves are sources of these inflammatory 
mediators. Indeed oxidative phosphorylation produces reactive oxygen species via electron leakage 
from the ETC primarily in complex I, but also from complex III under certain conditions (Cadenas 
et al. 1977; Murphy 2009; Turrens and Boveris 1980), although other mitochondrial sources have 
also been implicated (Andreyev et al. 2005). Baseline production of reactive oxygen species is 
considered to be an important element of mitochondrial signalling (Hamanaka and Chandel 2010). 
However, under pathological conditions, including hypoxia and inflammation, the electron leak can 
be intensified (Andreyev et al. 2005; Murphy 2009), resulting in mitochondria becoming a potent 
source of free radicals and creating a vicious cycle of mitochondrial damage and enhanced ROS 
production. In addition to their proximity to a potent free radical source, mitochondria are also 
particularly vulnerable to free radical mediated damage due to the ‘naked’ nature of their DNA, 
lacking protective proteins, such as histones (Bandy and Davison 1990; Larsson and Clayton 1995; 
Richter et al. 1988), and their limited DNA repair mechanisms, when compared with nuclear DNA 
(Bandy and Davison 1990; Clayton et al. 1974; Clayton 1982; Larsson and Clayton 1995). As a 
result mitochondrial DNA exhibits significantly more damage compared to its nuclear counterpart 
(Mecocci et al. 1993; Richter et al. 1988; Wang et al. 2005; Yakes and VanHouten 1997), 
highlighting the important role played by mitochondria in inflammatory pathogenesis. Such 
mitochondrial damage is expected to be particularly detrimental in large, post mitotic neurons, 
which perform limited glycolysis (Almeida et al. 2001) and require a functional pool of 
mitochondria to sustain high levels of energetically demanding activities (see next section 
“Neuronal sensitivity to mitochondrial damage”).  
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1.1.3.1. Neuronal sensitivity to mitochondrial damage 
Neurons are believed to rely primarily on oxidative phosphorylation as their primary source 
of ATP production (Almeida et al. 2001; Belanger et al. 2011; Sperlagh and Vizi 1996). As such 
they have been reported to undertake a higher level of oxidative phosphorylation when compared 
with glial cells (Bouzier-Sore et al. 2006; Lebon et al. 2002) and they are not able effectively to 
upregulate glycolysis when oxidative phosphorylation is inhibited, e.g. by NO (Almeida et al. 
2001). The inability of neurons to use glycolysis as a source for ATP was suggested to be related 
to the rapid degradation of Pfkfb3 (6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3) in 
neurons compared with for example astrocytes (Herrero-Mendez et al. 2009). Pfkfb3 is involved in 
the regulation of glycolytic enzymes via the synthesis of fructose-2,6-bisphosphate and therefore 
indirectly leads to the activation of the rate-limiting enzyme in glycolysis, 6-phosphofructo-1-
kinase (Yalcin et al. 2009). As such, the degradation of Pfkfb3 results in a suppression of glycolysis 
in neurons (Herrero-Mendez et al. 2009). This inhibition of the glycolytic pathway was found to be 
beneficial to the survival of neurons as an artificial increase in glycolysis, by the inhibition of the 
E3 ubiquitin ligase, responsible for the degradation of Pfkfb3, was found to divert glucose 
utilisation away from reduced glutathione production and subsequently led to increased levels of 
apoptosis (Herrero-Mendez et al. 2009). These findings therefore suggest that glycolysis cannot 
effectively sustain neuronal energetic demands and that glucose is instead preferentially used for 
antioxidant production in neurons.  
Such investigations also support evidence suggesting that glucose does not provide the 
primary fuel for ATP production in neurons but that other substrates may be more important for 
neuronal oxidative phosphorylation (Schurr 2006). Several lines of evidence now implicate lactate 
in neuronal energetic homeostasis (for review see (Belanger et al. 2011)). The astrocyte-neuron 
lactate shuttle hypothesis (Magistretti et al. 1999; Pellerin and Magistretti 1994) suggests that 
glutamate, released upon neuronal stimulation, gets taken up by astrocytes, with sodium being 
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cotransported. The resulting increase in astrocytic sodium levels stimulates ATP consumption by 
sodium-potassium-ATPases which actively pump sodium into the extracellular space. As a result 
of the decline in intracellular ATP, astrocytic glycolysis is activated and results in lactate 
production. This lactate is then made available to neurons as it is moved out of astrocytes and into 
neurons by monocarboxylate transporters where it fuels oxidative phosphorylation in neuronal 
mitochondria (reviewed in (Magistretti and Pellerin 1999)). Despite some controversy surrounding 
the astrocyte-neuron lactate shuttle hypothesis (Chih and Roberts 2003; Hall et al. 2012) there is 
significant evidence that lactate can provide an efficient fuel for oxidative phosphorylation in 
neurons (Schurr 2006). 
However, regardless of the substrate used, the reports summarised above suggest that 
neurons support their energetic needs mainly through oxidative phosphorylation resulting in great 
sensitivity towards mitochondrial dysfunction and oxygen deprivation. Together with the very high 
metabolic demand of cerebral tissue, which utilises 20% of the oxygen and 25% of the glucose 
consumption despite constituting only 2% of the body mass (Belanger et al. 2011; Lassen 1959), 
these findings suggest that neuronal function and survival relies fundamentally on mitochondrial 
oxidative phosphorylation and an adequate supply of oxygen. Such a reliance on mitochondrial 
function is demonstrated by the numerous neurodegenerative diseases in which mitochondrial 
dysfunction has been implicated (for review see (Federico et al. 2012; Lin and Beal 2006)), 
providing additional importance to the study of mitochondrial dysfunction and oxygen deprivation 
in the CNS.  
Overall, we have summarised putative links between inflammatory conditions and hypoxia. 
This combination is particularly detrimental in an environment of high NO production, which is 
capable of competing with oxygen for binding on complex IV, thereby increasing the apparent Km 
for oxygen and resulting in mitochondrial inhibition and eventually neuronal death even under mild 
hypoxic conditions (Mander et al. 2005). Furthermore, these partially inhibited mitochondria are 
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likely to be suffering from additional inflammatory insults, including DNA and protein damage 
from other inflammatory mediators, including reactive oxygen species. These factors together, 
suggest that inflammatory environments are likely to lead to significant bioenergetic dysfunction 
which could be of particular detriment to highly active and large cells, such as neurons, which rely 
primarily on oxidative phosphorylation for the production of ATP. Therefore, the study of 
oxygenation and mitochondrial function in neuroinflammatory conditions is of paramount 
importance in understanding and overcoming the putative energetic failures associated with 
inflammation of the CNS. 
1.2. Why in vivo 
Mitochondrial dysfunction is associated with a wide range of neurodegenerative diseases 
as described above. Notwithstanding the importance of mitochondria both as victims of 
inflammatory disease and as propagators of the damage, the assessment of their function in disease 
states has been slowed by limitations in traditional methods which are comprised principally of the 
post-mortem assessment of mitochondrial structure and morphology or in vitro assessment of 
mitochondrial function. These techniques provide a trade-off between dynamic assessment 
capabilities (during in vitro imaging for example) in the absence of physiological environments and 
fixation of more physiological preparations for post-mortem assessment which provides only very 
static snapshots of morphology with fewer opportunities to assess mitochondrial function. 
However, recent advances in in vivo imaging techniques have provided an opportunity to overcome 
some of these limitations and provide an additional technique to assess mitochondrial function. 
Indeed, intravital imaging offers the opportunity to maintain mitochondria within a physiological 
environment while also providing dynamic assessment capabilities with high spatial and temporal 
resolution. Unfortunately the tight experimental control which is relatively easily achieved in vitro 
is often more challenging within more complex preparations and may make causal attributions and 
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pathways difficult to assess. Additionally even physiological in vivo studies will have limitations 
in their applicability to human research, being constrained by the choice of the animal model, the 
organ system studied and type and depth of anaesthetic. Furthermore, in vivo optical imaging is 
only capable of probing the surface of the chosen organ, even using two-photon microscopy, as 
both the excitation and emitted light are readily scattered by overlying tissue. 
However, despite the complexity and limitations of intravital experimental design, it 
provides the opportunity to make more meaningful observations within more physiological 
preparations and is essential to the study of mitochondrial function in neurodegenerative diseases. 
Additionally, technical advancements are continuously being made, including the use of chronic in 
vivo imaging techniques which allow longitudinal assessment (Holtmaat et al. 2009; Yang et al. 
2010) even without anaesthetic (Dombeck et al. 2007) or the use of in vivo microscopy on human 
subjects including assessment of the retina (Webb et al. 1987) or skin (Masters et al. 1997). 
The benefits of intravital imaging are particularly relevant to the investigation of 
mitochondrial function in which the availability of oxygen and substrates can be of vital importance 
in the physiological and pathological regulation of this organelle. Particularly the substantial 
difference between the in vitro environment that mitochondria are exposed to, including aggressive 
extraction processes, elevated oxygen concentrations and non-physiological substrate levels, 
compared with the much more constrained situation faced by mitochondria in vivo, warrants 
significant investment into sound intravital imaging techniques. Such a highly physiological 
technique includes the visualisation of mitochondria even without external dye application, using 
the autofluorescent properties of electron carriers. This method provides a convenient signal for the 
minimally invasive assessment of mitochondrial function and neuronal activity in the superficial 
layers of the CNS in vivo as described below.  
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1.2.1. Mitochondrial redox potential in vivo 
Since the pivotal work of Britton Chance and his colleagues in the 1950s it has been 
apparent that the mitochondrial redox state can be assessed using the autofluorescent properties of 
redox cofactors. The mitochondrial cofactors, pyridine nucleotides (nicotinamide adenine 
dinucleotide (phosphate) NAD(P)/NAD(P)H) and flavoproteins (flavin mononucleotide and flavin 
adenine dinucleotide), transfer electrons to the electron transport chain, changing their redox 
potential in the process. Helpfully, only oxidized flavoproteins emit fluorescence when excited with 
blue light, while only reduced pyridine nucleotides are capable of fluorescing when excited with 
UV light. The respective reduced and oxidised counterparts of these cofactors do not have the same 
fluorescent properties, allowing the fluorescence, fluorometric and spectrofluorimetric assessment 
of the relative presence of oxidised flavoproteins and reduced pyridine nucleotides (e.g. (Chance et 
al. 1962; Chance and Baltscheffsky 1958; Chance and Connelly 1957; Chance and Jobsis 1959; 
Lewis and Schuette 1976; Lothman et al. 1975; Mayevsky et al. 1974; Mayevsky 1984; Mayevsky 
and Chance 1973; Mayevsky and Chance 1974; Quistorff et al. 1985)). The endogenous 
autofluorescent properties of these electron carriers have more recently been used to visualize 
mitochondrial redox potential in vivo, with the high spatial and temporal resolution afforded by 
standard fluorescence and laser based microscopy. NAD(P)H has additionally been imaged in vivo 
using two-photon microscopy (Kasischke et al. 2011; Takano et al. 2007) which allows better tissue 
penetration and less photodamage outside the focal area, when compared with single-photon UV 
excitation (Piston et al. 1995). As the signal generated by oxidized flavoproteins is weaker 
compared with that of reduced pyridine nucleotides (Chance et al. 1979; Koke et al. 1981) their 
assessment using two-photon excitation might be more difficult due to the localised excitation of 
two-photon lasers. To our knowledge two-photon microscopy has not been used in vivo to assess 
mitochondrial flavoprotein autofluorescence in the central nervous system, and anecdotal reports 
indicate that the technique has been applied, but attempts failed. In the current thesis, confocal 
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methods have been developed (despite some limitations, including low resolution in depth) to 
overcome the limitations of the two-photon approach. 
Because of the close relationship between neuronal activity, mitochondrial oxygen 
consumption and aerobic metabolism (Fein and Tsacopoulos 1988; Kann et al. 2003; Shibuki 1989; 
Shibuki et al. 2003) flavoprotein fluorescence has been used as a proxy for neuronal activation and 
the associated rise in oxidative metabolism (Gao et al. 2006; Husson et al. 2007; Reinert et al. 2004; 
Reinert et al. 2007; Reinert et al. 2011; Shibuki et al. 2003), as confirmed by optical imaging of 
intrinsic signals (Husson et al. 2007; Kitaura et al. 2007; Takahashi et al. 2006; Tohmi et al. 2006), 
calcium imaging (Gao et al. 2006), and field potential recordings (Kitaura et al. 2007; Takahashi et 
al. 2006; Tohmi et al. 2006). Additionally it was found that flavoprotein fluorescence can provide 
enhanced resolution for the localisation of cortical activity compared with changes in blood flow 
(Weber et al. 2004), which are the basis for the commonly used blood-oxygen-level dependent 
contrast imaging. The endogenous autofluorescence of oxidized flavoproteins therefore provides a 
very sensitive tool for the visualisation and assessment of the relationship between neuronal 
activation and oxidative metabolism, without the need for the application of dyes.  
For example, a series of experiments showed that stimulation of parallel fibres in the 
cerebellar cortex resulted in a temporary “beam-like” increase in flavoprotein fluorescence 
followed by a superimposed, delayed reduction in fluorescence (Gao et al. 2006; Reinert et al. 2004; 
Reinert et al. 2007; Reinert et al. 2011) (see Figure 1.2.1.1). It was possible to confirm the 
mitochondrial origin of the signal by its response to the mitochondrial inhibitors, cyanide (NaCN, 
blocks complex IV, preventing the transfer of electrons to oxygen and thereby maximally reducing 
the entire electron transport chain, including flavoproteins) and diphenyleneiodonium (DPI, 
inactivates flavoproteins) which abolished both phases of the signal without affecting neuronal 
excitability (Reinert et al. 2004). However, debate is still ongoing regarding the nature and origin 
of the components of this signal, with the initial increase in flavoprotein fluorescence suggested to 
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be due to the activation and depolarisation of neurons leading to a rapid increase in oxidative 
metabolism (Reinert et al. 2004; Reinert et al. 2011), while the subsequent dark phase was suggested 
to have at least a partial glial origin (Reinert et al. 2011). Other investigations have questioned the 
glial origin of the dark phase (Brennan et al. 2006).  
 
Figure 1.2.1.1: Diagrammatic representation of “beam like” autofluorescence changes 
following stimulation (as described in (Gao et al. 2006; Reinert et al. 2004; Reinert et al. 
2007; Reinert et al. 2011)). 
Stimulation of parallel fibres in the cerebellar cortex leads to a characteristic change in the 
flavoprotein autofluorescence including an initial increase in fluorescence in a “beam like” 
manner followed, after a stimulus dependent interval, by a superimposed decrease in 
fluorescence intensity. Additionally, parasagittal bands were described which appear along and 
across the “beam like” fluorescence changes and are stimulus independent. This diagram is 
roughly to scale with one cortical image representing around 1mm width. 
Together with this biphasic, beam-like signal, an ‘off-beam’ dark phase was also reported 
to be organised into parasagittal bands along and across the on-beam signal (Gao et al. 2006) (see 
also Figure 1.2.1.1.). This dark phase was suggested to originate from inhibitory interneurons, 
demonstrating the potential for mitochondrial redox state to offer information on inhibition 
(reduction of flavoproteins) as well as excitation (oxidation of flavoprotein pool) of postsynaptic 
neurons (Gao et al. 2006). In a separate study it was found that the off-beam reduction in the 
flavoprotein signal following stimulation was diminished in spinocerebellar ataxia type 8, while the 
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on-beam increase in fluorescence was augmented, suggesting reduced inhibition by cerebellar 
interneurons and altered cerebellar circuity (Moseley et al. 2006). Such findings demonstrate that 
the endogenous flavoprotein signal is sensitive enough to provide clinically relevant information. 
In comparison with the effects of physiological stimulation, cortical spreading depression, 
which has been associated with pathological mechanisms after traumatic brain injury, stroke, 
subarachnoid haemorrhage and migraine (Ayata et al. 2006; Lauritzen et al. 2011; van den 
Maagdenberg et al. 2004), has been reported to result in larger changes in redox state in vivo 
(Takano et al. 2007). By virtue of the high spatial and temporal resolution of two-photon NAD(P)H 
imaging it was possible to visualise a striking spatial relationship between the cortical redox state 
and the cortical vasculature during cortical spreading depression. This relationship was comprised 
of an initial, global decline in NAD(P)H fluorescence, which remained stable close to vessels, but 
was replaced by a localised increase in fluorescence further away from vessels (Takano et al. 2007). 
This therefore revealed a close relationship between the cortical vascular network and redox state, 
which is not evident during rest but is uncovered during situations of high oxygen demand which 
are capable of exceeding the rate of oxygen delivery, revealing areas of greater ischemic 
vulnerability and enhanced pyridine nucleotide fluorescence. It is not surprising therefore, that the 
application of oxygenated cerebral spinal fluid to the cortex prevented the spreading depression 
induced and spatially selective increase in NAD(P)H fluorescence, as the spatial relationship to the 
oxygen source was lost (Takano et al. 2007). These findings therefore highlight the importance of 
a preserved vascular network within a physiological preparation when investigating mitochondrial 
function during physiological and pathological events. 
Physiological, intact, whole animal preparations are also beneficial when investigating 
cortical networks, long-range plasticity and the mitochondrial involvement in them. For example, 
in vivo autofluorescence of flavoproteins was used to assess cortical plasticity in the visual, auditory 
and somatosensory cortex (Shibuki et al. 2006; Takahashi et al. 2006; Tohmi et al. 2006), and to 
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investigate long-range neural plasticity pathways in response to tetanic stimulation (Murakami et 
al. 2004). It was even possible to use flavoprotein autofluorescence to visualise the retinotopic and 
tonotopic maps of the visual and auditory cortex respectively (Husson et al. 2007; Takahashi et al. 
2006; Tohmi et al. 2006). Therefore, the possibility of instantaneous assessment of mitochondrial 
redox potential over a large area, spanning both hemispheres, permits the mapping of neural 
plasticity in vivo. Indeed such large and complex networks cannot easily be investigated with 
electrodes (due to the number of recordings needed) or ex vivo preparations in which long-range 
pathways are unlikely to be intact. 
The absorbing properties of flavoproteins have been useful not only in terms of 
visualisation of fluorescence but also for the inhibition of neuronal function. Prolonged (50 
minutes) blue light exposure allows for the targeted inactivation of flavoprotein fluorescence and 
therefore oxidative metabolism (Kubota et al. 2008). Using this technique Kubota et al were able 
to show that information processing in the primary auditory cortex is partly driven by signals 
originating from the anterior auditory field, as photo-inactivation of the latter area reduced 
subsequent stimulus processing (visualised by flavoprotein fluorescence) in the former, while 
inactivation of the primary auditory cortex left stimulus processing in the anterior auditory field 
intact (Kubota et al. 2008). By virtue of the high spatial sensitivity of optical techniques, photo-
inactivation of mitochondrial metabolism and neuronal function can be achieved in a highly 
localised manner, providing greater sensitivity compared with many pharmacological interventions.  
Overall, many benefits are associated with the use of flavoprotein and pyridine nucleotide 
autofluorescence in the assessment of neuronal and mitochondrial function. Without the use of dyes, 
issues associated with loading, distribution and toxicity are avoided while a stable signal (Shibuki 
et al. 2003) with excellent spatial (Husson et al. 2007; Shuttleworth et al. 2003) and temporal 
resolution (Husson et al. 2007; Weber et al. 2004) is maintained over large areas. Nonetheless, the 
autofluorescent signals generated are relatively weak, and the endogenous NAD(P)H and 
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flavoprotein fluorescence strength can vary depending on the laser intensity and imaging depth, as 
well as the preparation quality. These limitations can make absolute and baseline measurements 
meaningless, and instead the experimental design needs to assess longitudinal changes across the 
duration of the experiment.  
Generally the autofluorescence of mitochondrial electron carriers can offer a convenient, 
spatially and temporally sensitive, and minimally invasive, readout of mitochondrial redox potential 
and neuronal activity in a physiological, whole-animal preparation with an intact blood supply, in 
the superficial layers of the central nervous system in vivo.  
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CHAPTER TWO 
2. Flavoproteins in the cortex 
2.1. Introduction 
A wide range of diseases, including MS (Erecinska and Silver 2001;  Mahad et al. 2008), 
Parkinson’s disease (Schapira et al. 1998), and sepsis (Fink 2002a), have been associated with 
mitochondrial dysfunction. This extensive involvement of mitochondria in a multitude of 
pathological processes emphasizes the need for a better understanding of the role of mitochondrial 
function in health and disease. However, assessment of mitochondria in large parts of the published 
literature relies on in vitro assays, which are far removed from physiological reality. Therefore, the 
need for dynamic in vivo assessment of mitochondrial function with both spatial and temporal 
resolution remains, as discussed above. 
2.1.1. Flavoprotein fluorescence as a 
measure of mitochondrial function 
Mitochondrial function can be assessed in vitro and more recently in vivo using confocal 
or two-photon microscopy and membrane potential-sensitive dyes, like tetramethylrhodamine 
methyl ester (TMRM) or through autofluorescent markers, including oxidized flavoproteins and 
reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H). As mentioned in the 
introduction (chapter 1), oxidized flavoproteins and reduced NAD(P)H (pyridine nucleotides) 
exhibit fluorescent properties (Reinert et al. 2004) that differ significantly from those of their 
reduced and oxidized counterparts, respectively (Figure 2.1.1.1). This allows the mitochondrial 
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redox potential to be mapped with the spatial and temporal resolution provided by the chosen 
imaging technique.  
 
Figure 2.1.1.1: Diagrammatic representation of flavoprotein, pyridine nucleotide and 
TMRM fluorescence. 
Abbreviations: GSH, reduced glutathione; GSSG, oxidized glutathione; FMN, flavin 
mononucleotide; FAD, flavin dinucleotide; ETF, electron transfer flavoproteins; LipDH, 
lipoamide dehydrogenase; αKGDH, alpha ketoglutarate dehydrogenase; PDH, pyruvate 
dehydrogenase complex; TCA, tricarboxylic acid cycle. 
Flavoproteins are primarily found in mitochondria (Huang et al. 2002; Koke et al. 1981; 
Scholz et al. 1969). Here both flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) 
are present. Although several enzymes in mitochondria contain these molecules the local 
environment mostly quenches their fluorescent properties (Kunz and Kunz 1985; Ragan and 
Garland 1969) and instead mainly flavins from electron transfer flavoproteins (transferring 
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electrons from β-oxidation of fatty acids to ubiquinone) and α-lipoamide dehydrogenase (involved 
in the conversion of pyruvate to acetyl-CoA and in the tricarboxylic acid cycle, as a component in 
the α-ketoglutarate dehydrogenase complex) seem to contribute significantly to redox linked 
flavoprotein autofluorescence (Kunz and Gellerich 1993; Kunz and Kunz 1985) (Figure 2.1.1.1). It 
should be noted however, that β-oxidation is limited in the brain as fat is not a major fuel source. 
In line with this the brain shows a limited uptake of fatty acids (Hawkins 1986) and has a reduced 
pool of enzymes for the β-oxidation pathway (Yang et al. 1987), including electron transfer 
flavoproteins (Kunz and Gellerich 1993). Therefore, the brain’s flavoprotein signal is likely to be 
dominated by α-lipoamide dehydrogenase, together with a proportion of green fluorescence which 
does not seem to be redox sensitive (Kunz and Gellerich 1993; Kunz and Kunz 1985). 
NAD(P)H fluorescence refers to the combined signal from NADH and NADPH. While 
NADH, as a cofactor for the ETC, provides a proxy for oxidative metabolism, it is also involved in 
glycolysis and thereby anaerobic metabolism (Kasischke et al. 2004). In contrast, the 
phosphorylated form, NADPH, is involved in biosynthetic reactions and antioxidant production as 
a reducing equivalent in, for example, nucleotide and lipid synthesis as well as glutathione reduction 
(Ying 2008) (Figure 2.1.1.1). NADH and NADPH are spectrally indistinguishable, preventing 
separation of the two signals using standard confocal or two-photon microscopy. Therefore, given 
the involvement of pyridine nucleotides also in reactions outside mitochondria, for example 
biosynthetic pathways or glycolysis (Ying 2008) they have also been detected in the cytosolic 
compartment (Blacker et al. 2014; Kasischke et al. 2004; Patterson et al. 2000). Nevertheless an 
inverse relationship has been reported between flavoprotein and pyridine nucleotide fluorescence 
(Chisholm et al. 2015; Mayevsky 1984; Shuttleworth et al. 2003) partly attributed to the dominance 
of the mitochondrial NAD(P)H signal in the brain (Klaidman et al. 1995; Shuttleworth 2010).  
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2.1.2. Oxygen supply to the cortex 
Mitochondrial respiratory function depends on the availability of oxygen. As electrons are 
passed to the successively higher affinity electron acceptors along the ETC, O2 acts as the final 
acceptor of these electrons. Therefore, hypoxic conditions can result in the blockage of electron 
flow, accumulation of electrons along the ETC and the reduction of a number of components of the 
ETC (e.g. (Scholz et al. 1969; Sugano et al. 1974)). This mitochondrial reduction, in the absence of 
oxygen, can be visualized using flavoprotein and/or pyridine nucleotide fluorescence (Chisholm et 
al. 2015; Kasischke et al. 2011). 
Despite the relatively small mass of the brain (2% of body mass (Raichle and Gusnard 
2002)) it has been reported to consume 20% of the oxygen taken up by the human body at rest 
(Lassen 1959), emphasizing the essential need for a functional oxygen supply to the brain. Indeed, 
unconsciousness ensues only 5-6 seconds following the arrest of cerebral blood flow (Rossen et al. 
1943). However, despite large regional variations in cortical oxygen concentrations (Erecinska and 
Silver 2001), oxygen is usually provided to cells at a sufficient rate to sustain tissue oxygen levels 
above the concentration necessary for function under basal conditions (Erecinska and Silver 2001). 
Historically the capillary network has been accredited with the supply of oxygen to tissues with 
each capillary suggested to supply a distinct cylindrical region (Krogh 1919). More recently 
however it has been suggested that oxygen diffusion can also occur from arteries and arterioles, 
including pial vessels (Duling et al. 1979; Duling and Berne 1970; Ivanov et al. 1982; Ivanov et al. 
1999; Sakadzic et al. 2010; Vovenko 1999). However, the published literature has largely relied on 
oxygen probe measurements, which lack spatial resolution. A separate study has made use of the 
phosphorescent quenching properties of oxygen and utilized the resulting lifetime changes of 
phosphorescent bead to assess changes in vascular and tissue oxygen concentrations throughout the 
cortex (Sakadzic et al. 2010). However, to our knowledge only one study investigated the spatial 
relationship between the oxygenation provided via pial arterioles and mitochondrial function 
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(Kasischke et al. 2011). Further studies are necessary to confirm the spatial and temporal 
responsiveness of mitochondrial function to changes in pial arterial oxygenation. 
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2.2. Hypotheses 
1) The endogenous fluorescence of flavoproteins can be used to assess mitochondrial 
redox state in vivo in the CNS of anaesthetized mice 
2) Hypoxaemia results in selective reduction of mitochondrial flavoproteins with 
preserved oxidation in well oxygenated areas 
2.3. Aims and objectives  
In order to assess the spatial distribution of mitochondrial redox potential in relation to the 
cortical vasculature in real time in the mouse cerebral cortex during normoxaemia, hyperoxaemia 
and hypoxaemia, our initial aim is to assess the applicability of endogenous flavoprotein 
fluorescence as a proxy for mitochondrial redox state in the exposed murine cerebral cortex in vivo 
using confocal microscopy. To achieve this aim our first objective was to confirm the mitochondrial 
origin of the endogenous green fluorescence imaged in the cerebral cortex of anaesthetised mice 
using pharmacological agents known to manipulate mitochondrial redox potential. Having 
established a measure of mitochondrial redox potential we then aim to determine the effects of 
changes in cerebral oxygenation on flavoprotein fluorescence by manipulating the inspired oxygen 
fraction (FiO2). Finally changes in flavoprotein fluorescence will be compared to changes in other 
markers known to be influenced by the mitochondrial redox potential.  
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2.4. Methods 
C57bl/6 mice (~20 g) were housed in a 12 hour light/dark cycle with food and water ad 
libitum. All experiments were performed in accordance with the UK Home Office Animals 
(Scientific Procedures) Act (1986). 
2.4.1. Surgery 
Mice were anaesthetised with ~2% isoflurane in room air for most experiments, but a 
mixture or ketamine (20mg/kg) and urethane (2g/kg), injected intraperitoneally (i.p.), was used 
when NAD(P)H and flavoprotein fluorescence were imaged together. Mice were then placed on a 
homeothermic heating mat to maintain their rectal temperature at 37oC, and an incision was made 
in the scalp to expose the skull. The skull was subsequently cleaned of connective tissue, and affixed 
to a titanium bar for stability using dental cement (Contemporary Ortho-Jet Powder, USA) mixed 
with cyanoacrylate glue (Loctite, Henkel Ltd., UK). A craniotomy (~5mm diameter) was performed 
to expose part of the right hemisphere, between bregma and lambda and lateral to the sagittal suture. 
The exposed dura was moistened and cleaned with saline. The opening was surrounded by a ring 
of petroleum jelly (Vasline, Unilever, UK) over which a circular glass coverslip (6mm) was placed 
to seal the craniotomy and prevent evaporation during imaging. Following surgery, the mice were 
moved to a custom-made stage for confocal or two-photon microscopy. 
2.4.2. Dyes 
In a subset of experiments, oxygen-sensitive microbeads impregnated with a 
phosphorescent dye, platinum(II)-5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin 
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(PtPFPP, courtesy of Dmitri Papkovsky; excitation 543 nm; emission: 650 nm, collected with 585 
nm long pass filter) were added to cover the dura (5 µl of 5 mg/ml aqueous suspension, 5 minutes 
incubation before the application of a coverslip). Alternatively, the dura was removed and the 
exposed cortex incubated with TMRM (Molecular Probes, Invitrogen, UK; 1µM; excitation: 
561nm, emission: 584-656), isolectin GS–IB4 from Griffonia simplicifolia (Life technologies, 
Thermo Fisher Scientific, UK, 400µM, excitation: 488nm, emission: 505-570nm) and/or 4-amino-
5-methylamino-2',7'-difluorofluorescein (DAF-FM, Life Technologies, Molecular Probes, 
Invitrogen, UK; 1µM, excitation: 488nm, emission: 505-570nm) for 30 minutes before the 
coverslip was added as described before (see Figure 2.4.2.1). 
 
Figure 2.4.2.1. Summary of the protocol used for dyes and treatments 
2.4.3. Interventions 
In experiments using carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) or 
sodium cyanide (NaCN) the dura was removed and no coverslip was used. Instead a silicone well 
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was drawn around the exposed cortex (Body Double, Smooth-On Inc., USA) and filled with 40µl 
saline. During time lapse imaging 2µl of saline from the well was replaced with NaCN or FCCP 
(working concentration of 5mM and 10µM, respectively, see Figure 2.4.2.1). Five of the time lapse 
images were averaged, seconds or minutes after application, once the image stabilized.  
Room air exposure was achieved with a room air pump while other variations of FiO2 were 
controlled by mixing oxygen and nitrogen at appropriate concentrations. Oxygen variations were 
conducted as a gradual decrease from 21% O2 downwards in 1% increments until death occurred or 
as 5 minutes interval variations as follows: 21%, 100%, 21%, 15%, 21%, 10%, 21% and 5% 
oxygen, until death. 
2.4.4. Microscopy 
The endogenous flavoprotein signal (excitation: 488nm, emission: 505-570nm) and all dyes 
described were imaged with a LSM 5 Pascal laser-scanning confocal microscope (Zeiss, Germany), 
using time lapse recordings with an in-plane resolution of 512 by 512 pixels and an optical slice 
thickness of 896 μm. Endogenous NAD(P)H (excitation: 720, emission: 430-480) was imaged using 
a Zeiss 510 NLO META equipped with a Coherent Chameleon Ti:sapphire laser. 
2.4.5. Image analysis 
Images were processed using Fiji/ImageJ Version 1.48v (NIH, USA). Time-lapse 
sequences were aligned using the ‘Stackreg’-Plugin. Areas of interest were selected using the free 
hand selection tool. To assess the flavoprotein fluorescence three regions of interest were selected 
around arteries, and three around veins, followed by a calculation of the ratio of these areas. The 
change in the ratio of periarterial over perivenular fluorescence intensity was compared during 
different FiO2 conditions. To assess changes in cortical oxygenation the average intensity of 
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phosphorescent microbeads close to arteries and close to veins was determined separately and 
compared across conditions of variable FiO2. Statistical significance was assessed using the IBM 
SPSS Statistics 22 package and a p ≤ 0.05 was considered significant.  
2.5. Results 
2.5.1. Endogenous fluorescence in the naïve 
cortex 
During normoxia (21% inspired O2) a green autofluorescent signal was present uniformly 
throughout the cortex, except where obscured by the vasculature, which was highlighted in negative 
contrast. We distinguished arteries from veins by their morphology, and their uniform outline, 
which was typically highlighted as brightly fluorescent walls (Figure 2.5.1.1). The arterial nature 
of these vessels was confirmed using DAF-FM diacetate (Figure 2.5.1.1) which is non-fluorescent 
until it reacts with nitric oxide, as nitric oxide is expressed by the endothelial cells of arteries, from 
where it diffuses to the surrounding smooth muscle (Bateman et al. 2003). 
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Figure 2.5.1.1: Arteries can be distinguished morphologically and by their arterial wall 
Left: green autofluorescence; right DAF-FM (green) and TMRM (red) fluorescence. The nitric 
oxide label, DAF-FM, confirms the arterial nature of vessels with thicker, DAF-FM positive 
walls compared with veins. Scale bar = 200µm 
Brightly fluorescent puncta can be seen in the naïve cortex imaged for green 
autofluorescence (Figure 2.5.1.1). When time lapse recordings are taken at higher magnification 
(63x) it is possible to see movement of the brightly fluorescent puncta (data not shown). These 
puncta also labelled with isolectin (Figure 2.5.1.2) suggesting that these are perivascular 
macrophage/microglia (Kaur and Ling 1991). 
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Figure 2.5.1.2: Isolectin mirrors the punctate pattern of green autofluorescence in the 
murine cortex.  
(a) Isolectin (green) / TMRM (red) in 10x magnification, scale bar = 200µm. Bright puncta in 
isolectin labelled cells replicate the pattern seen with autofluorescence imaging. (b) Higher 
magnification (63x) reveals direct colabelling of bright perivascular autofluorescent puncta with 
isolectin (arrows). Scale bar = 100µm. 
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2.5.2. Endogenous fluorescence is 
mitochondrial in origin 
The putative mitochondrial origin of the green autofluorescence in the cerebral cortex was 
explored by use of agents known to influence the redox state of flavoproteins. Application of NaCN 
is known to result in the reduction of a number of components of the ETC (Hackenbr 1968) and 
this was confirmed by a significant reduction in fluorescence intensity (~35%). Application of 
FCCP instead oxidizes the ETC and also significantly increased the fluorescence intensity (~23%; 
Figure 2.5.2.1), as expected. The control treatments (application of HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffered saline or DMSO (Dimethyl sulfoxide) in saline (1:500) for 
NaCN and FCCP respectively) did not significantly affect the autofluorescence signal. These data 
are therefore in line with the proposition that the endogenous green fluorescence imaged here 
originates from oxidized mitochondrial flavoproteins. 
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Figure 2.5.2.1: Confirmation of the mitochondrial origin of endogenous green fluorescence.  
(a) Representative images of flavoprotein fluorescence before and after the addition of NaCN 
and FCCP showing a decrease and increase in the flavoprotein signal respectively. Scale bar = 
100µm. (b) Quantification of the change in fluorescence intensity before and after the addition 
of cyanide and FCCP. Data displayed as mean ± SEM. Significance is compared between the 
change in signal after application of DMSO vs FCCP, * = p ≤ 0.05 and between the change in 
the signal after application of HEPES buffered saline vs NaCN, ** = p ≤ 0.01. 
2.5.3. Hypoxaemia affects the flavoprotein 
fluorescence 
 
Increasing FiO2 from 21% to 100% had no effect on the signal amplitude or distribution. 
Reducing FiO2 (to ≤ 10%) however, resulted in a marked change in flavoprotein fluorescence. This 
change was characterised by a decrease in fluorescence intensity which preferentially affected areas 
around veins and tissue remote from arteries. This left a ‘halo’ of preserved autofluorescence in 
55 
 
tissue adjacent to arteries and arterioles (Figure 2.5.3.1 a). This pattern typically appeared at 5-10% 
inspired oxygen. In contrast, smaller decreases in FiO2 (e.g. 15%) had no effect on the flavoprotein 
signal (Figure 2.5.3.1 b).  
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Figure 2.5.3.1: Flavoprotein and TMRM fluorescence during hypoxaemia. 
 (a) Representative images of changes in cortical flavoprotein and TMRM fluorescence in 
response to changes in FiO2. An increase in inspired oxygen above 21% did not change the 
flavoprotein fluorescence or the TMRM fluorescence. However a decrease in FiO2 to ≥ 10% O2 
reduces the flavoprotein and TMRM signal with preserved signal only around the arteries. Scale 
bar = 200µm. (b) Quantification of flavoprotein fluorescence represented as the ratio of 
periarterial over perivenular fluorescence intensity (representative selections displayed in (a), red 
= periarterial selection, blue = perivenular selection). Data displayed as mean ± SEM. 
Significance was assessed between changes in inspired oxygen and the initial room air condition. 
* = p ≤ 0.05, ** = p ≤ 0.01, n = 21. (c) Profile plot showing the change in flavoprotein 
fluorescence during changes in FiO2 in a representative tissue section (represented in the bottom). 
Blue indicates low fluorescence intensity, yellow represents high fluorescence intensity.  
To confirm the accuracy of our quantification of the change in flavoprotein fluorescence 
with hypoxaemia, we compared the chosen method (hand selection of three periarterial and three 
perivenular areas and the creation of a ratio, see method, chapter 2.4.5) with a more detailed method. 
This method involved the hand selection of a ‘halo’ of 20-30µm around all vessels, instead of a 
selection of only six areas. 
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Figure 2.5.3.2: Quantification of flavoprotein signal change. 
Assessment of the accuracy of the measure used to quantify the flavoprotein signal change with 
hypoxaemia. Two methods of quantification were compared. One method (solid lines) involved 
the hand selection of three periarterial and three perivenular areas and the creation of a ratio. 
The second method (dotted lines) is more exhaustive and involves the free hand selection of a 
20-30µm halo around all vessels and the creation of a periarterial to perivenular ratio. Each 
colour represents one separate experiment with 5 experiments being compared in total. 
In most cases no considerable difference between the two assessment methods was 
observed (Figure 2.5.3.2.). The occasional discrepancy between the two forms of quantification 
(red lines) could be due to surgical damage which could have left some areas of the brain non-
responsive to hypoxaemia. Such areas can be avoided when selecting 6 areas. Therefore all further 
quantification of flavoprotein ratios will reflect the ratio of three hand selected areas around arteries 
and three hand selected areas around veins. 
The relatively abrupt appearance of the change in fluorescence intensity (Figure 2.5.3.1 c) 
suggests a sharp threshold at which cortical mitochondrial function is affected by changes in 
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inspired oxygen. Indeed, when hypoxaemia was introduced more gradually, with a 1% decrease in 
inspired oxygen every 3 minutes, it became obvious that changes in flavoprotein fluorescence occur 
very abruptly between 7-9% inspired oxygen, despite a continuous and gradual decline in arterial 
oxygenation saturation (Figure 2.5.3.3). It seemed that arterial haemoglobin oxygen saturation (as 
assessed by arterial pulse oximetry) needed to be around 55% O2 before an effect on cortical 
mitochondria can be visualised (Figure 2.5.3.3). 
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Figure 2.5.3.3: Flavoprotein fluorescence and arterial haemoglobin saturation. 
(a) Change in flavoprotein fluorescence and arterial haemoglobin saturation with gradual 
increases in hypoxaemia. Data displayed as mean ± SEM. Flavoprotein signal n = 4; arterial 
oxygen saturation n = 2. (b) Profile plot showing the change in flavoprotein fluorescence during 
gradual changes in FiO2 in a representative tissue section (represented in the bottom at 15% 
inspired O2 and at the top at 8% inspired O2). Blue indicates low fluorescence intensity, yellow 
represents high fluorescence intensity. 
Additionally, reductions in flavoprotein fluorescence were reversible if the animals were 
returned to room air and were able to recover (Figure 2.5.3.1 b and c). It should also be noted that 
some animals showed an increased flavoprotein fluorescence following recovery (23% showed a 
very clear increase in flavoprotein signal upon recovery). 
Further we explored whether changes in flavoprotein fluorescence were also associated 
with changes in mitochondrial membrane potential. To examine this we assessed the effects of 
hypoxaemia on TMRM fluorescence. We observed the same arterial ‘halos’ of preserved TMRM 
fluorescence at 5-10% FiO2 as with flavoprotein autofluorescence (Figure 2.5.3.1 a). The change in 
the flavoprotein fluorescence in the merged image is not due to bleed through from TMRM as 
equivalent flavoprotein fluorescent changes occur also in the absence of TMRM loading (Figure 
2.5.3.1 a). 
The changes in the distribution of the flavoprotein fluorescence at reduced FiO2 varied 
inversely with NAD(P)H fluorescence (Figure 2.5.3.4). This is because NAD(P)H can be visualised 
when it, and the mitochondrial ETC, are reduced. This pattern is in opposition to flavoprotein 
autofluorescence which only fluoresces in the oxidized state. However neither NAD(P)H nor 
flavoproteins are expected to provide significant signal inside vessels. Therefore it is not surprising 
that the absence of flavoprotein and NAD(P)H signals converge in vessels (Figure 2.5.3.4) 
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Figure 2.5.3.4. Flavoprotein and pyridine nucleotide fluorescence during hypoxaemia 
(a) Representative images of flavoprotein and NAD(P)H fluorescence during hypoxaemia. Scale 
bar = 60µm. (b) Graphical representation of a small section of tissue (highlighted in red in the 
merged image in (a) and at the bottom of the graph). In cortical parenchyma flavoprotein and 
NAD(P)H fluorescence tend to diverge as flavoprotein fluoresce when oxidized and NAD(P)H 
when reduced. In vessels the signals will converge due to absence of fluorescence. 
Using oxygen-sensitive phosphorescent beads we were also able to show that changing the 
FiO2 resulted in a corresponding change in cortical tissue oxygen, as expected (Figure 2.5.3.5). The 
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oxygen-sensitive beads increased in fluorescence intensity with a decrease in available oxygen, 
exhibiting an approximately 3-fold increase in the fluorescence intensity when O2 is reduced from 
21% to 0%.  
 
Figure 2.5.3.5. Change in cortical oxygenation assessed by oxygen sensitive beads 
(a) Representative image of oxygen sensitive phosphorescent beads (orange beads) on a cortex 
imaged for flavoprotein fluorescence (green). Beads close to the arteries (red arrows) were 
analysed separately from beads further away (blue arrows). (b) Quantification of fluorescence 
intensity changes with changes in inspired oxygen. The reciprocal of the fluorescence intensity 
was graphed. Data displayed as mean ± SEM. ** = p ≤ 0.01 
When the FiO2 was increased to 100%, a significantly larger decrease in fluorescent 
intensity was observed in periarterial beads which were defined as being within the ‘halo’ of 
preserved flavoprotein fluorescence, compared with beads located further away from arteries 
(Figure 2.5.3.5 b). However, other changes in FiO2 did not lead to differences between the change 
of periarterial and the change of perivenular bead fluorescence, suggesting that oxygenation in areas 
around the arteries and areas further away responds similarly to reductions in inspired oxygen or 
that the beads were not sensitive enough to detect more subtle changes.  
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2.6. Discussion 
We demonstrated that it is possible to use flavoprotein autofluorescence, imaged using 
standard confocal microscopy, in the cortex of anaesthetized mice, as a measure of mitochondrial 
redox potential. Using this measure we further showed that cortical mitochondrial function is 
selectively compromised at low concentrations of inspired oxygen. The impairment is selective for 
perivenular areas and tissues further away from arteries, with preservation of mitochondrial redox 
potential along arteries and arterioles. This pattern of selective mitochondrial dysfunction during 
hypoxaemia demonstrates the role of arteries and arterioles in the direct supply of oxygen to 
cerebral tissue. 
2.6.1. Flavoprotein signal represents 
mitochondrial redox potential 
The use of flavoprotein autofluorescence as an indicator of mitochondrial redox potential 
is well established (Chance et al. 1979; Huang et al. 2002; Reinert et al. 2004; Scholz et al. 1969) 
but its application in intravital fluorescence microscopy to assess mitochondrial function in the CNS 
has been limited. To our knowledge endogenous flavoprotein fluorescence has not been used 
previously to evaluate cortical redox state in response to changes in inspired oxygen with the high 
spatial and temporal resolutions of confocal microscopy shown here. 
We used pharmacological interventions to vary the mitochondrial redox potential in cortical 
mitochondria in order to confirm the mitochondrial origin of the green autofluorescence. A variation 
in the redox state was achieved using the well characterised agents NaCN and FCCP. NaCN is 
known to block complex IV and thereby prevent the transfer of electrons to oxygen. This inhibitor 
therefore causes a build-up of electrons on the ETC and leads to reduction of the ETC and the 
mitochondrial redox potential. This reduction in the redox potential corresponds to a decrease in 
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flavoprotein fluorescence. FCCP instead acts as an uncoupling agent thereby allowing protons to 
cross the inner mitochondrial membrane without passing through complex V. This maximally 
stimulated mitochondrial respiration (Benz and Mclaughlin 1983) and thereby leads to the oxidation 
of mitochondria, including flavoproteins. And as a result we observed an increase in flavoprotein 
autofluorescence corresponding to an increase in its oxidation state.  
The source of the endogenous flavoprotein fluorescence was further validated by 
simultaneous imaging of flavoprotein and NAD(P)H fluorescence. NAD(P)H is known to fluoresce 
when reduced and has been previously imaged in the cortex in vivo (Kasischke et al. 2011; Takano 
et al. 2007). Reduced pyridine nucleotides therefore provide the fluorescence counterpart of 
oxidized flavoproteins and are expected to vary inversely. This is indeed what we found when 
exposing the mouse to a reduction in inspired oxygen. In the absence of oxygen (the final electron 
acceptor) the electrons build up on the ETC and thereby lead to a reduction of mitochondrial redox 
potential, which results in a decrease in flavoprotein fluorescence concomitant with an increase in 
pyridine nucleotide fluorescence in the cerebral cortex in vivo.  
2.6.2. Reductions in FiO2 reveal arterial 
oxygenation of the cortex 
Under normoxic conditions (21% inspired oxygen) we found that the oxygen supply to the 
brain was sufficient to sustain functional mitochondria uniformly throughout the cortex in 
agreement with previous reports (Erecinska and Silver 2001). Increasing the concentration of 
inspired oxygen had no effect on flavoprotein autofluorescence, suggesting that oxygen availability 
was not a rate limiting factor in flavoprotein oxidation under these conditions. This is in contrast to 
previous studies which found an increase in NAD(P)H fluorescence also under an FiO2 of 21% 
(Kasischke et al. 2011), suggesting that also under normoxaemia the cortex exhibits tissue patches 
in which mitochondria are reduced. This can be explained by the use of different autofluorescent 
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fluorophores (namely pyridine nucleotides) or possibly also by differences in the preparation of the 
cranial window. Specifically Kasischke et al.’s experimental design involved the removal of the 
dura mater, while our set-up left this intact. The removal of the dura can lead to enhanced swelling 
of the cortex which can cause the obstruction of blood vessels along the edge of the cranial window 
hampering perfusion to the cranial window and thereby possibly resulting in unintentional cortical 
hypoxia.   
In our experiment a small reduction in the FiO2 to 15% also had little influence on the 
mitochondrial redox potential suggesting that an FiO2 of 15% in a healthy, anaesthetised animal is 
still sufficient to maintain a healthy pool of oxidized mitochondria throughout the cortex. A further 
decrease in the concentration of inspired oxygen to less than 10%, however, resulted in a 
characteristic change in the flavoprotein signal. This consisted of a reduction of flavoprotein 
autofluorescence in avascular areas away from arterioles and areas close to venules with 
preservation of oxidized flavoprotein autofluorescence along pial arteries and arterioles, similar to 
previous investigations (Kasischke et al. 2011). The loss of flavoprotein fluorescence was further 
investigated by a gradual decrease in FiO2. This revealed a sudden loss of flavoprotein fluorescence 
around 7-9% inspired oxygen which in our experiment corresponds to an approximately 55% 
arterial haemoglobin oxygen saturation. This is in line with previous findings showing that 
reductions in systemic oxygenation need to be severe before they have an influence on healthy 
cortical mitochondria (Chance et al. 1962; Macmillan and Siesjo 1972). Indeed, Chance et al, using 
fluorometry, found that the cortical NAD(P)H signal only increased at concentrations of inspired 
oxygen below 8% (Chance et al. 1962) which reflects our observations. This reduced level of 
oxygen happens to align well with the so called “death zone” experienced at extreme altitudes, 
above 30 000 feet (height of Everest), where sustained habitation and human acclimatisation have 
been said to be impossible (Huey and Eguskitza 2001). Here the oxygen concentration is 
approximately 34% of that at sea level leaving an oxygen concentration of around 7% (Huey and 
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Eguskitza 2001). Of course only limited parallels can be drawn between the extreme conditions 
endured on Mount Everest and those experienced by an anaesthetised rodent. 
 If hypoxaemia is sufficient it very abruptly leads to dysfunctional cortical mitochondria 
despite a gradual decrease in systemic oxygenation (as assessed by pulse oximetry). The spatial 
pattern seen with flavoprotein autofluorescence in response to changes in FiO2 was also observed 
with TMRM fluorescence, suggesting that other measures of mitochondrial function such as 
membrane potential are also affected by hypoxaemia. We were able to assess TMRM and 
flavoprotein fluorescence simultaneously showing concordance between the two signals. We also 
imaged these separately in different populations of animals to show that the change in flavoprotein 
fluorescence does not correspond to TMRM signal bleed through. Preservation of 
flavoprotein/TMRM fluorescence and loss of NAD(P)H fluorescence in periarterial tissue is not 
consistent with the historical assumption that oxygen delivery to organs is limited to capillaries 
(Krogh 1919). Instead these data support more recent evidence that arteries and arterioles play a 
major role in delivering oxygen directly to tissue (Ivanov et al. 1982; Ivanov et al. 1999; Sakadzic 
et al. 2010; Vovenko 1999). Furthermore, our results also show that the oxygen delivered via 
cortical arteries and arterioles is physiologically relevant and maintains mitochondrial function 
during hypoxaemia, in line with previous work (Kasischke et al. 2011). Therefore, we have shown 
not only that oxygen delivery to tissue is not limited to capillaries but also that the delivery of the 
oxygen through arterioles is of relevance to tissue function. 
It should also be noted, that if the animals were allowed to recover after a reduction in FiO2, 
under ≥ 21% O2, the loss of flavoprotein signal was reversible. Additionally a subset of mice (23%) 
showed even an enhancement of the flavoprotein autofluorescence after recovery from the 
hypoxaemia. We were unable to find a correlate to this enhanced recovery. One might speculate 
that this increase in flavoprotein signal after recovery from hypoxaemia could be related to 
mitochondrial transition pore opening during ischemia/reperfusion injury (Honda et al. 2005) which 
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can lead to an uncoupling of mitochondrial oxidative phosphorylation (Brenner and Moulin 2012; 
Halestrap et al. 1998) and a resultant increase in oxidation of mitochondrial flavoproteins (as seen 
after the application of FCCP, described above). Indeed, it is known that mitochondrial membrane 
depolarisation, as seen here with TMRM, increases the probability of the opening of the 
permeability transition pore (Bernardi et al. 1993; Honda et al. 2005; Ly et al. 2003; Petronilli et al. 
1993). However, formal testing of this hypothesis would be needed and might include the inhibition 
of permeability transition pore opening by e.g. cyclosporine A. 
2.6.3. Cortical microglia/macrophages 
distribution can be visualized using 
endogenous green fluorescence 
The uniform coverage of green autofluorescence seen in the cortex, originating from 
mitochondrial flavoprotein, is interspersed by bright fluorescent puncta throughout the parenchyma. 
This signal is unaffected by reductions in inspired oxygen or the addition of cyanide, suggesting 
that it is not mitochondrial in nature. Previous in vitro studies have also found such non-
mitochondrial autofluorescence and have implicated lysosomes (Andersson et al. 1998). This is in 
line with our observations using high magnification time-lapse imaging which revealed that moving 
circular structures, consistent with lysosomes, make up the autofluorescent bodies. Furthermore, it 
is known that microglia/macrophages have autofluorescent properties (Edelson et al. 1985; Xu et 
al. 2008) which could originate from their lysosomes (Koenig 1963). To test whether the brightly 
fluorescent puncta seen in the cerebral cortex of anaesthetized mice do originate from 
microglia/macrophages we applied isolectin (which is known to label macrophages/microglia (Kaur 
and Ling 1991)) to the surface of the cortex. The co-labelling of isolectin with the autofluorescent 
puncta suggests that these are indeed cortical microglia/macrophages. This finding illustrates yet 
another opportunity for autofluorescent imaging: the assessment of microglia and macrophages 
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without the application of exogenous dyes. The origin of the fluorescence in the 
microglia/macrophages/lysosomes is not within the scope of this research but it has been suggested 
to derive from the accumulation of waste products such as lipofuscin (Xu et al. 2008) and/or non-
mitochondrial flavoprotein autofluorescence, as both inducible nitric oxide synthase and the 
respiratory burst are associated with flavoproteins (Babior 1984; Clark 1990; Clark 1999; Hevel et 
al. 1991; Stuehr et al. 1991). 
2.6.4. Changes in FiO2 can be detected by 
oxygen sensitive microbeads 
Changing the concentration of inspired oxygen resulted in a corresponding change in 
cortical oxygenation as assessed by oxygen-sensitive microbeads. Hyperoxia was found to have a 
differential effect on periarterial and perivenular tissue oxygenation while no measurable difference 
in the reduction in periarterial and non-arterial tissue oxygenation was detected at ≤ 21% FiO2, 
despite the decrease in oxidized flavoprotein distal to arteries. This however does not mean that 
arterial and venous oxygenations are not different, as absolute measurements were not possible 
using oxygen sensitive microbeads. However, it does mean that, according to our oxygen sensitive 
microbeads, periarterial and non-arterial regions are similarly affected by reductions in inspired 
oxygen but that arterial regions are more affected by hyperoxic conditions. This is in line with 
previous studies (Bergofsk and Bertun 1966) and might be related to a decrease in blood flow with 
hyperoxia (Bergofsk and Bertun 1966; Kennedy et al. 1971; Lambertsen et al. 1953; Leahy et al. 
1980; Watson et al. 2000) which can lead to a greater oxygen extraction by the tissue and a relatively 
reduced venous oxygen outflow (Bergofsk and Bertun 1966). 
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2.7. Limitations and further research  
As mentioned in the introduction, both NAD(P)H and flavoprotein fluorescence originate 
from a number of different sources. However, our data does not differentiate between these sources. 
It is believed that flavoprotein fluorescence originates primarily from the FAD cofactor in α-
lipoamide dehydrogenase and/or electron transfer flavoproteins together with some non-redox 
reactive fluorescence (Kunz and Gellerich 1993; Kunz and Kunz 1985). Small spectral variations 
in α-lipoamide dehydrogenase and electron transfer flavoprotein fluorescence allowed the 
differentiation of these signals (Lam et al. 2012; Rocheleau et al. 2004). However, spectral overlap 
remains extensive and more ready differentiation might be achieved with fluorescence lifetime 
imaging (FLIM). Briefly, FLIM records the decay rate of fluorophores from an excited state. 
Practically this involves excitation with a femtosecond laser and recording of the rate of release of 
photons after the excitation event. Different molecules will have different decay properties but even 
similar molecules can vary in their decay characteristics based on their immediate environment. 
The local environments and binding partners of flavoprotein cofactors in α-lipoamide 
dehydrogenase and electron transfer flavoproteins provide good theoretical grounds for the likely 
differentiation of these molecules with FLIM. Indeed, FLIM has been used to differentiate the 
phosphorylated and un-phosphorylated reduced pyridine nucleotides from each other both in vitro 
and ex vivo (Blacker et al. 2014) showing that the fluorescence originating from NADPH is not 
negligible (Blacker et al. 2014). The different environments and binding partners of NADH and 
NADPH allows for FLIM differentiation of these two molecules when bound to different structures 
(Blacker et al. 2014), while free NAD(P)H cannot be differentiated by FLIM imaging (Blacker et 
al. 2013).  
Therefore, a future improvement of the current technique might include the use of 
FLIM to differentiate the origin of the flavoprotein and NAD(P)H signal in vivo in the 
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cortex and comparing the fluorescence lifetimes in the CNS with fluorescence lifetimes in 
other organs where the ratio of these fluorophores is expected to be different. It has been 
stated that neither NADPH nor electron transfer flavoproteins are extensively present in 
brain tissue (Klaidman et al. 1995; Kunz and Gellerich 1993; Shuttleworth 2010). This is 
in contrast to the liver where β-oxidation occurs more extensively and thereby the electron 
transfer flavoprotein content is expected to be higher compared to the brain (Kunz and 
Gellerich 1993). However as the signal generated by oxidized flavoproteins is weaker 
compared with that of reduced pyridine nucleotides (Chance et al. 1979; Koke et al. 1981) 
their assessment using two-photon excitation might be more difficult due to the localised 
excitation of two-photon lasers. Therefore, the use of pulsed single-photon lasers might be 
necessary which allows for greater signal collection following the loss of resolution in the 
z-plane by opening of the pinhole. The feasibility of this would have to be determined 
experimentally. 
2.8. Conclusion 
In conclusion, we demonstrated that it is possible to use flavoprotein 
autofluorescence to assess mitochondrial redox potential in vivo in the central nervous 
system with the spatial and temporal resolution afforded by fluorescence microscopy and 
that this signal is sensitive enough to reflect changes in mitochondrial redox state both in 
response to mitochondrial inhibitors and hypoxaemia. Changes in mitochondrial redox 
potential were revealed in the cerebral cortex of hypoxaemic mice, as demonstrated by a 
regionally selective decrease in flavoprotein fluorescence in areas away from arteries and 
tissue surrounding veins. These reductions in mitochondrial redox potential are associated 
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with corresponding changes in mitochondrial membrane potential. The preservation of 
oxidized flavoproteins and membrane potential in periarterial tissue is consistent with the 
direct supply of oxygen from arteries and arterioles to cortical tissue. Additionally 
endogenous green fluorescence can also be used to assess resident microglia without the 
application of dyes. However, further characterization of the autofluorescent signal is 
necessary to reveal the exact origin of mitochondrial flavoprotein fluorescence. 
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CHAPTER THREE 
3. Mitochondrial function in the CNS 
during systemic inflammation 
3.1. Introduction 
Having characterised flavoprotein fluorescence in the cortex of naïve and hypoxaemic mice 
we were interested in assessing the relationship between mitochondrial redox potential and 
hypoxaemia during systemic inflammation as a murine model of sepsis. 
3.1.1. Sepsis and the brain 
Sepsis is a serious medical condition estimated to be the 11th most common cause of death 
in 2010 (Murphy et al. 2013). Furthermore the incidence of sepsis is expected to rise in the future 
with an increasingly aged and immunosuppressed population (Singer and Brealey 1999). Multiple 
organ dysfunction and failure is the leading cause of death during sepsis and other intensive care 
conditions (Gustot 2011; Thijs et al. 1996). The brain is not spared from sepsis related dysfunction 
and it is indeed common for septic patients to have brain dysfunction which can range from mild 
confusion to coma and these symptoms have been associated with increased mortality (Adam et al. 
2013). Despite the wide reaching impact of sepsis, the mechanism by which it leads to multiple 
organ dysfunction and especially encephalopathy is still unclear. 
As sepsis can be caused by a large number of bacterial, fungal or viral insults and displays 
a very broad clinical spectrum with large individual variation, it is a difficult disease to model 
(Wichterman et al. 1980). Not only the initial infection, but particularly the host immune response 
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has been consistently implicated in the disease pathology of sepsis and inflammatory response 
syndrome (Bone et al. 1997; Bopp et al. 2008; Flemming 2011; Goris et al. 1985). Given the 
immune system’s dual nature of host protection and injury it is a very difficult pathway to target 
therapeutically (Bone et al. 1997). Given this inherent difficulty in the study of the immune response 
in sepsis and its clear importance in disease pathology, we decided to model the inflammatory 
component of sepsis without the complication of a true bacterial infection. For this we used a mild 
model of systemic endotoxemia, induced by a systemic injection of LPS which is a component of 
the cell wall of Gram-negative bacteria, known to induce a strong inflammatory reaction. Systemic 
LPS has frequently been used as a model of sepsis (Fink et al. 1987; Matsumoto et al. 2001; 
Peyssonnaux et al. 2007) and it presents a well characterised inflammatory model which mirrors 
some essential aspects of sepsis.  
3.1.2. Sepsis and mitochondrial dysfunction 
Extensive research has shown that sepsis is associated with mitochondrial dysfunction in 
several tissues, including skeletal muscle  (Brealey et al. 2002; Brealey et al. 2004; Tavakoli and 
Mela 1982), liver  (Brealey et al. 2004; Crouser et al. 2002a; Kantrow et al. 1997; Mela et al. 1971; 
Tavakoli and Mela 1982), and kidney (Mela and Miller 1983) and the idea of a bioenergetics failure 
has grown in acceptance in recent years. Even in a mild model of sub-acute septicaemia evidence 
of mitochondrial dysfunction has been reported (Tavakoli and Mela 1982) and early on in the 
induction of sepsis in rats Schaefer et al detected mitochondrial abnormalities using near infrared 
spectroscopy (Schaefer et al. 1991), suggesting that mitochondrial dysfunction is an early player in 
sepsis associated pathology. Indeed, a link has been established between disease severity, 
mitochondrial dysfunction and patient outcome (Brealey et al. 2002) and it has been suggested that 
patients may frequently die not of the initial infection per se (Bone et al. 1997) but rather because 
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of factors that persist even if the infection has been successfully combatted, such as a pronounced 
energy imbalance (Brealey and Singer 2003).  
Mitochondrial dysfunction can result from an inadequate supply of oxygen and extensive 
evidence has linked sepsis and sepsis-related organ dysfunction to microvascular disturbances and 
poor organ perfusion (De Backer et al. 2013; De Backer et al. 2014; Lam et al. 1994). Indeed, 
dysfunction in sublingual microcirculation was associated with patient outcome as non-survivors 
showed more severe alterations compared to survivors (Bateman and Walley 2005; De Backer et 
al. 2013) and therapies aimed at microcirculatory recovery have shown promise (Anning et al. 1999; 
Bateman and Walley 2005; Spronk et al. 2002). Reduced cerebral blood flow has also been reported 
in patients (Bowton et al. 1989; Maekawa et al. 1991) and animal models (Crouser 2004; 
Ekstromjodal and Larsson 1982) although others have found no abnormalities (Lang et al. 1984; 
Pollard et al. 1997).  
Given such evidence implicating mitochondrial dysfunction, inadequate perfusion and 
bioenergetic failure in sepsis it is expected that factors which reduce energy supply further, 
including hypoxaemia, could be particularly detrimental in sepsis. In contrast, it is expected that 
factors which reduce energy demand, such as hypothermia, may be protective. 
Indeed, hypothermia has been successfully applied to several critical care conditions and 
has shown particular potential for neuroprotection (Bernard and Buist 2003; Polderman and Herold 
2009). On the other hand, a recent clinical study of therapeutic hypothermia in bacterial meningitis 
had to be prematurely abandoned because of increased harm  (Mourvillier et al. 2013). Murine 
models of sepsis have a rapid onset of hypothermia, with the magnitude of change being related to 
reduced oxygen consumption and increased mortality rates  (Zolfaghari et al. 2013). Thus the 
impact of therapeutic hypothermia is uncertain.   
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3.2. Hypotheses 
1) Systemic inflammation affects the CNS and can result in hypoxia which can affect 
mitochondrial resilience to additional energetic challenges (hypoxaemia) 
2) Hypothermia can offer protection to CNS mitochondria during energetic challenges 
induced by systemic inflammation 
3.3. Aims and objectives 
In the previous chapter and in published work we have shown that the endogenous green 
fluorescence of flavoproteins can be used to assess mitochondrial redox potential in vivo in the CNS 
(Chisholm et al. 2015). We are now able to use this protocol to assess changes in cortical 
mitochondrial sensitivity to an energetic challenge (hypoxaemia) in a murine model of sepsis. 
Additionally we will assess whether cortical oxygenation is affected by endotoxemia thereby 
investigating a possible mechanism for putative increased mitochondrial vulnerability in cortices 
of endotoxic mice. Having assessed cortical mitochondrial vulnerability to hypoxaemia during 
systemic inflammation we can then test the efficacy of hypothermia to regulate this possible 
energetic imbalance and attenuate the enhanced sensitivity of endotoxic mice to reductions in 
inspired oxygen.  
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3.4. Methods 
C57bl/6 mice (~20 g) were housed in a 12 hour light/dark cycle with food and water ad 
libitum. All experiments were performed in accordance with the UK Home Office Animals 
(Scientific Procedures) Act (1986). 
3.4.1. Model 
Following a pilot dosing experiment (described in chapter 4), mice were injected with LPS 
(from Escherichia coli, Sigma-Aldrich, USA; i.p. 5mg/kg in saline, 0.01ml/g) or saline alone. After 
the injection mice were placed back into normal housing conditions until surgery. 117 Mice were 
randomly allocated to one of nine conditions (Table 3.4.1.1) and a further fifteen mice were 
designated for assessment of cortical oxygenation (n = 5 (2 saline and 3 LPS) per time point: 6, 24, 
48 hours post-injection) 
 
6 hrs post 
injection 
24 hrs post 
injection 
48 hrs post 
injection 
Saline 
Normothermia (37˚C) n = 17 n = 13 n = 7 
n = 21 
Spontaneous 
temperature 
n = 13 n = 13 - 
n = 10 
Induced hypothermia 
(32˚C) 
n = 13 - - 
n = 10 
Table 3.4.1.1: Experimental conditions and n numbers.  
Nine conditions include different temperatures and times post-injection. It should be noted that 
an unequal distribution of numbers resulted from variable mortality rates with different disease 
and treatment conditions. 
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3.4.2. Craniotomy 
Surgery was performed as described previously for the assessment of flavoprotein 
fluorescence in the cortices of anaesthetised mice (chapter 2). Briefly, isoflurane (~2%) was used 
to anaesthetise mice. A homeothermic heating mat maintained their rectal temperature at the desired 
level (either normothermia (37˚C), induced hypothermia (32˚C) or the spontaneous temperature 
exhibited immediately after anaesthesia). Following anaesthesia the skull was exposed and 
stabilised by fixation to a titanium bar (with dental cement and cyanoacrylate glue). A partial 
craniotomy over the right hemisphere exposed the underlying cortex which was cleaned and 
moistened with saline and covered with a circular glass coverslip, 6mm in diameter, and sealed with 
petroleum jelly. Following these preparations the mice were transferred to a custom-made stage for 
confocal microscopy. In a subset of mice (n = 27) oxygen-sensitive microbeads impregnated with 
a phosphorescent dye, PtPFPP, were added to partially cover the dura (5 µl of 5 mg/ml aqueous 
suspension). 
3.4.3. Oxygen probe measurements 
Fifteen mice were anaesthetised as above using isoflurane (~2% in room air) and core body 
temperature was measured and controlled at 37˚C via a rectal probe and homeothermic heating mat. 
A small opening of approximately 2mm in diameter was drilled into the skull of the right 
hemisphere to expose the underlying cortex. The dura mater was removed from a small area of the 
craniotomy for easier probe insertion. The fibre optic tip of an oxygen sensing probe (OxyMicro, 
World Precision Instruments, USA; assessing the phosphorescent quenching properties of oxygen) 
was inserted into the cortex using a micromanipulator. The probe was inserted to a depth of 700µm 
from the cortical surface, followed by a retraction of 100µm, to a final recoding depth of 600µm 
from the cortical surface. While measurements were continuously taken the FiO2 was reduced by 
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the addition of nitrogen to room air for 5 minute intervals as follows: 0.21, 0.15, 0.21, 0.10, 0.21, 
0.5, until death.  
3.4.4. Microscopy 
Confocal time-lapse recording were conducted using the LSM 5 Pascal laser-scanning 
confocal microscope (Zeiss, Germany) with an in-plane resolution of 512 by 512 pixels and an 
optical slice thickness of 896μm. Endogenous flavoprotein signal was excited using a multi-line 
argon laser with a 488nm wavelength. Emission was collected around a band of 505-570nm. The 
oxygen-sensitive phosphorescent beads were imaged using a helium-neon laser at an excitation 
wavelength of 543nm or a diode laser with an excitation wavelength of 405nm (the two lasers were 
used because of a change in the microscope system in our laboratory). Emission was collected with 
a 585nm long pass filter. During continuous time-lapse imaging the FiO2 was varied as described 
above. 
3.4.5. Electrocardiograms 
Electrocardiograms (ECG) were recorded in a subset of animals (n = 53) using conventional 
electrophysiological equipment (Neurolog, Digitimer, UK). For this, a reference electrode 
(hypodermic needle) was placed in the right hind foot of the mouse and a ground and recording 
electrode (hypodermic needles) were inserted subcutaneously in the back and chest of the mouse 
respectively. The ECG record was displayed on a digital oscilloscope (Sigma 60, Nicolet 
Technologies, USA) and recorded manually at regular intervals. 
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3.4.6. Analysis 
Images were processed as described in chapter 2 using Fiji/ImageJ Version 1.48v. Again 
time-lapse sequences were aligned and areas of interest selected. For flavoprotein analysis three 
regions of interest were selected immediately adjacent to arteries and three adjacent to veins 
followed by the calculation of the ratio of these averaged areas. A difference in the change in the 
ratio of periarterial over perivenous fluorescence in response to reductions in inspired oxygen was 
compared between groups. To assess the differential responsiveness of oxygen sensitive beads to 
changes in inspired oxygen between groups the average intensity of phosphorescent microbeads 
was determined for the last five cycles of each oxygen manipulation and compared across 
conditions. To assess absolute changes in cortical oxygenation the traces of the oxygen probe were 
averaged over the last minute of each oxygen manipulation and compared across conditions. 
Statistical significance was assessed using the IBM SPSS Statistics 22 package and a p ≤ 0.05 was 
considered significant.  
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3.5. Results 
3.5.1. Clinical signs 
Systemic endotoxemia resulted in the appearance of clinical signs, including sedation, 
hunched appearance, piloerection, ocular discharge and hypothermia (Zolfaghari et al. 2013). 
Additionally weight loss was observed after LPS injection but not consistently after saline injection 
(Table, 3.5.1.1). Indeed, weight loss comparisons between saline and LPS injected mice were highly 
significant at all time-points (for 6 hours: p ≤ 0.01, for 24 hours and 48 hours: p ≤ 0.001, Table 
3.5.1.1) 
  Saline LPS 
6 hrs  - 0.35 (±0.08) gr - 0.7 (±0.05) gr ** 
24 hrs  + 0.42 (±0.36) gr - 1.91 (±0.12) gr *** 
48 hrs  + 0.37 (±0.27) gr - 2.01 (±0.44) gr *** 
Table 3.5.1.1: Change in weight of mice 6, 24 and 48 hrs after an injection of saline or LPS. 
Mean ± SEM. Two-tailed t-test comparisons were made between LPS and saline injected groups. 
** = p ≤ 0.01, *** = p ≤ 0.001. 
Additionally core body temperature dropped significantly 6 hours (33.05˚C ± 0.4; p ≤ 
0.001) and 24 hours (32.98˚C ± 0.65; p ≤ 0.001) but not 48 hours (35.57 ± 0.6; p ≥ 0.05) after LPS 
injection when compared with saline controls (35.9˚C ± 0.14). 
There was a significant positive correlation between weight loss and temperature 24 hours 
after LPS injection (r=0.798, p ≤ 0.001 Spearman’s rank correlation coefficient) such that animals 
with a higher core body temperature 24 hours after LPS injection had lost more weight (Figure 
3.5.1.1). This was not the case 6 hours after LPS injection (r=0.000, p ≥ 0.05). 
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Figure 3.5.1.1: Correlation between weight loss and core body temperature 6 and 24 hrs 
after LPS injection.  
Mortality was increased in endotoxic mice compared to saline-injected controls but 
hypothermia (both spontaneous and induced) significantly enhanced resilience to increased levels 
of hypoxaemia 6 hours after endotoxaemia (Figure 3.5.1.2 a): During progressive hypoxaemia, 
LPS-injected mice died at higher FiO2 values compared to saline-injected controls. However, 
hypothermia (both spontaneous and induced) improved tolerance to hypoxaemia in endotoxic mice 
6 hours after LPS (Figure 3.5.1.2 a). 
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Figure 3.5.1.2: Mortality and heart rate during systemic inflammation. 
(a) Survival of mice subjected to systemic inflammation/saline and hypoxaemia. (b) Changes in 
heart rate between groups. Data displayed as mean ± SEM. ** = p ≤ 0.01; *** = p ≤ 0.001. 
There was no measurable difference in the heart rate between LPS and saline-injected mice. 
However, spontaneous hypothermia reduced the heart rate significantly, at both 6 and 24 hours after 
LPS injection (Figure 3.5.1.2 b). 
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3.5.2. Systemic inflammation affects 
flavoprotein signal in the cerebral cortex 
during hypoxaemia 
In chapter 2 and a previous publication (Chisholm et al. 2015) we reported that healthy 
animals subjected to hypoxaemia showed a characteristic reduction in the cortical flavoprotein 
fluorescence revealing areas of vulnerability in tissues distant from arteries and close to veins, with 
a ‘halo’ of preserved flavoprotein fluorescence around arteries (‘arterial halo’ pattern). We show 
this here again (Figure 3.5.2.1). In saline-injected mice this ‘arterial halo’ pattern appeared at the 
same FiO2, regardless of the time from injection (data not shown). Therefore, the data collected 
from mice injected with saline were pooled. All mice exposed to room air showed a relatively even 
flavoprotein signal covering the cortex uniformly (Figure 3.5.2.1). Also an increase in inspired 
oxygen to 100% had no influence on the flavoprotein signal on animals in any groups (Figure 
3.5.2.1), as discussed in the previous chapter. Also saline-injected animals exposed to 15% inspired 
oxygen did not show any variation in their cortical flavoprotein signal, in agreement with our 
previous data (chapter 2). If however, the amount of inspired oxygen was decreased further to 10%, 
a subset of mice (11 of 21) showed a characteristic change in the cortical flavoprotein fluorescence 
exemplified by the ‘arterial halo’ pattern. If the FiO2 was reduced further to 5% all but two saline 
injected animals showed this characteristic change in the flavoprotein signal. If however, the mice 
were injected with LPS 6 hours prior to the imaging session the flavoprotein signal decreased 
already at 15% inspired oxygen, notably a concentration at which the flavoprotein fluorescence 
does not change in healthy, saline-injected controls (Figure 3.5.2.1). Most animals (65%) injected 
with LPS 6 hours previously also did not survive 15% oxygen (Figure 3.5.1.2 a). By 24 hours after 
LPS injection, mice showed an attenuated sensitivity of the flavoprotein autofluorescence to 
reductions in inspired oxygen. At 24 hours after LPS injection 77% (10/13) of mice showed a 
change in the signal between 15% inspired oxygen and 10% inspired oxygen (Figure 3.5.2.1) which 
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was concomitant with improved survival when compared with the 6 hours post LPS injection group 
(Figure 3.5.1.2 a). At 48 hours after LPS injection clinical signs, survival and flavoprotein signal 
sensitivity to changes in inspired oxygen recovered back to saline control values (Figure 3.5.1.2 a 
and 3.5.2.1). 
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Figure 3.5.2.1: The sensitivity of flavoprotein signal to changes in inspired oxygen is affected 
by systemic endotoxemia.  
(a) Flavoprotein signal changes in endotoxic and control mice with changes in inspired oxygen. 
In blue = representative selection of perivenular tissue, in red = representative selection of 
periarterial tissue. Scale bar = 200µm. (b) Quantification of the change in endogenous 
flavoprotein fluorescence around veins relative to arteries. An increase in the ratio of periarterial 
over perivenular fluorescence indicates the appearance of the ‘arterial halo’ pattern. Data are 
displayed as means ± SEM. ** = p (Saline vs 6 hrs LPS) ≤ 0.01. It should be noted that where 
images or data are missing in the visual representation, a high mortality rate would have made 
these unrepresentative and as a result they were removed from the display but not from the 
analysis. 
As mentioned in the previous chapter, the reduction in the flavoprotein fluorescence with 
hypoxaemia was reversible in animals that were allowed to recover from hypoxaemia during room 
air exposure. In these cases the ‘halo’ of preserved flavoprotein fluorescence expanded until it 
covered the cortex again, and the ratio returned back to ~1 (Figure 3.5.2.1 b). 
3.5.3. Oxygenation of the cortex 
Oxygenation of the cortex was assessed using an oxygen microsensor inserted into the 
cortex at a depth of 600µm. However, given the need for a separate cohort of animals when the 
oxygen microsensor was used, changes in oxygenation were also assessed using oxygen-sensitive 
microbeads (introduced in chapter 2) in the imaging cohort of animals. This allowed us to confirm 
changes in cortical oxygen with changes in FiO2 while simultaneously assessing flavoprotein 
fluorescence. 
The level of oxygen in the cortices of saline-injected control mice (46.5 ± 3.0 mmHg) was 
significantly higher compared with mice injected with LPS 6 hours (29.3 ± 5.6 mmHg; p ≤ 0.01, 
single tailed t-test) and 24 hours (34.3 ± 6.1 mmHg; p ≤ 0.05) prior, as assessed by oxygen probe 
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measurements at an FiO2 of 0.21. This pattern continued also at lower concentrations of inspired 
oxygen although the differences did not always reach significance (Figure 3.5.3.1). By 48 hours the 
oxygen levels in cortices of LPS-injected animals had recovered to control levels (46.9 ± 5.9 mmHg, 
Figure 3.5.3.1). 
 
Figure 3.5.3.1: Cortical oxygen during systemic endotoxemia 
(a) Oxygen concentration of the cortex during reductions in FiO2. With a decrease in the amount 
of inspired oxygen the cortical oxygenation decreased in all groups. However, the overall cortical 
oxygenation was lower in endotoxic animals compared to saline injected controls at 6 and 24 hrs. 
This reduced cortical oxygenation in endotoxic animals recovered by 48hrs. (b) Change in 
cortical oxygen concentration between two room air conditions. The first room air exposure 
provided the initial baseline condition, before any change in inspired oxygen. The second room 
air exposure separated the 15% and 10% inspired oxygen conditions. This reveals that most 
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animals did not recover fully back to the baseline room air condition after a 5 minute exposure 
to hypoxaemia. However, the recovery rate is non-significantly different between groups, 
suggesting that the recovery from hypoxaemia to room air was achieved equally in all conditions 
(endotoxic and control). Data displayed as mean ± SEM. ** = p (saline vs 6 hrs LPS) ≤ 0.01, * 
= p (saline vs 24 hrs LPS) ≤ 0.05, one tailed t-test. 
Although none of the groups recovered fully back to the original room air values following 
the initial reduction in inspired oxygen to 15%, the decrease in cortical oxygenation in the two room 
air conditions were not significantly different between groups (Figure 3.5.3.1 b, one-way ANOVA, 
p ≥ 0.05 on the change in oxygenation between the two room air conditions across groups), 
suggesting that the recovery rate for all groups of animals was comparable.  
The change in cortical oxygenation with changes in FiO2 was also confirmed using oxygen-
sensitive phosphorescent microbeads (Figure 3.5.3.2). 
 
Figure 3.5.3.2: Oxygen-sensitive beads in systemic inflammation 
(a) Example distribution of oxygen-sensitive microbeads on the cortical surface. Scale bar = 
100µm (b) Relative changes in cortical oxygen (shown as the reciprocal of the fluorescence 
intensity of the sensor bead) with changes in FiO2. The data are normalized to the initial room air 
condition. Data presented as mean ± SEM.  
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It should be noted that the fluorescence intensity of individual beads was influenced by 
their size and the focal plane. As a result absolute values were meaningless and instead the beads 
were normalized to the initial room air condition and only relative changes in the fluorescence 
intensity with changes in inspired oxygen are considered. Additionally, as a decrease in oxygenation 
resulted in an increase in fluorescence intensity of the oxygen-sensitive beads, the reciprocal of the 
fluorescence intensity is shown here, to allow an easier graphical representation and more accessible 
comparison with the data from the oxygen probe. Although endotoxic mice, particularly 24 hours 
after endotoxemia, seemed more reactive to changes in oxygen, particularly hyperoxia, this 
difference was not statistically significant. 
3.5.4. Spontaneous hypothermia attenuates 
increased sensitivity of mice with systemic 
inflammation 
In order to assess the effect of spontaneous temperature changes (known to occur in septic 
mice (Zolfaghari et al. 2013)) on the sensitivity of the flavoprotein fluorescence to hypoxaemia we 
conducted a study in which we kept all mice at their spontaneous temperature measured 
immediately after anaesthesia. The average core body temperature of saline injected mice was 
35.9˚C (± 0.14). Accordingly, this group (saline-injected, spontaneous temperature) showed a very 
similar ‘arterial halo’ pattern response to differences in FiO2 as saline-injected mice kept at 37˚C. 
Instead mice injected with LPS 6 hours prior to the imaging session showed spontaneous 
hypothermia of 33.05˚C (± 0.4) shortly after anaesthesia. If this spontaneous hypothermia was 
maintained during imaging, the cortical mitochondria of these mice were protected from 
hypoxaemia relative to their normothermic, LPS injected counterparts, which were forcibly kept at 
37˚C during the preparation and imaging session (Figure 3.5.4.1). Indeed, the ‘arterial-halo 
pattern’ response to changes in FiO2 in this group of animals (6 hours LPS imaged at their 
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spontaneous temperature) is similar to that seen in saline-injected controls (Figure 3.5.4.1). Also 
the resilience to increasing levels of hypoxaemia (hereafter termed “survival”) of endotoxic mice 
after 6 hours was improved when they were kept under their spontaneous hypothermia and 
compared with normothermic counterparts, though mortality was still higher than in saline-injected 
controls (Figure 3.5.1.2 a). 
 
Figure 3.5.4.1: Spontaneous hypothermia protects cortical mitochondria from hypoxaemia.  
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(a) Changes in cortical flavoprotein signal during changes in FiO2 in saline and LPS-injected 
animals kept at their spontaneous temperature. Scale bar = 200µm (b) Quantification of the ratio 
of periarterial over perivenular fluorescence in saline- and LPS-injected animals kept at their 
spontaneous temperature and at 37˚C. Data displayed as mean ± SEM. ** = p (6 hrs LPS 37˚C 
vs spontaneous temp) ≤ 0.01. 
At 24 hours, LPS-injected mice also had an average hypothermic temperature of 32.98˚C 
± 0.65. If they were kept at their spontaneous temperature during imaging they were not protected 
from hypoxaemia in terms of survival or cortical mitochondrial function (Figure 3.5.1.2 a and 
3.5.4.1). However, it is noteworthy that fewer LPS-injected animals survived surgery 24 hours after 
LPS when kept at forced normothermia (37˚C) compared with animals left at their spontaneous 
hypothermic temperature. This group of animals was not included as no imaging data could be 
collected. 
3.5.5. Induced hypothermia protects against 
hypoxaemia 
As we observed a protective effect of spontaneous hypothermia in LPS-injected animals 
(both in terms of survival and ‘arterial-halo’ pattern onset in response to reductions in FiO2) at 6 
hours, we sought to determine the effects of hypothermia on healthy, saline-injected control mice. 
To achieve this, both healthy and LPS-injected mice (6 hours post injection) were kept at an induced 
hypothermia of 32˚C during surgery and imaging. This hypothermia was protective for saline- and 
LPS-injected mice. Compared with their normothermic counterparts (37˚C), saline-injected mice, 
kept at 32˚C, showed an ‘arterial-halo’ pattern response at lower FiO2 (5%) and exhibited improved 
survival (Figure 3.5.5.1 and 3.5.1.2 a). 
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Figure 3.5.5.1: Induced hypothermia protects cortical mitochondria from hypoxaemia.  
(a) Changes in cortical flavoprotein signal during changes in FiO2 in saline and LPS-injected 
animals 6 hours after endotoxemia kept at 32˚C. Scale bar = 200µm. (b) Quantification of the 
ratio of periarterial over perivenular fluorescence. Data displayed as mean ± SEM.  
Also endotoxic mice were protected from hypoxaemia when hypothermia was induced 
(32˚C), both in terms of survival and ‘arterial-halo’ pattern response to reductions in FiO2, 
compared with their normothermic controls kept at 37˚C (Figure 3.5.1.2 a and 3.5.5.1). However 
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the protection afforded to LPS-injected mice (6 hours) by induced hypothermia (32˚C) was less 
than that provided to mice kept at their spontaneous temperature.  
3.6. Discussion 
Much evidence implicates bioenergetic failure in sepsis and multiple organ dysfunction, 
e.g. (Balestra et al. 2009). We therefore investigated whether hypoxaemia, which provides an 
additional energetic challenge, promoted mitochondrial dysfunction in the cortices of mice 
subjected to mild systemic endotoxemia. As shown in the previous chapter and a publication, we 
found that mitochondrial dysfunction, assessed by a selective loss of flavoprotein autofluorescence 
(Chisholm et al. 2015), is pronounced during hypoxaemia and reveals areas of cortical vulnerability 
between vessels and along veins, with protected ‘halos’ of preserved flavoprotein fluorescence 
close to arteries (Chisholm et al. 2015; Kasischke et al. 2011). Additionally we now report that such 
areas of vulnerability are more readily revealed at higher concentrations of inspired oxygen in 
endotoxic mice when compared with healthy, saline-injected counterparts. Such findings suggest 
an increased vulnerability towards hypoxaemia in the cortices of mildly endotoxic animals. 
However, due to the lack of baseline assessments combined with the clear presence of a clinical 
presentation even during room air conditions we are not able to rule out that this cortical 
vulnerability may be an epiphenomenon as far as the symptoms of the model are concerned. The 
increased vulnerability, with this non-lethal model of systemic inflammation, was only temporary 
with a peak observed at 6 hours and a complete recovery by 48 hours post LPS injection. 
3.6.1. Vascular dysfunction in sepsis 
The observation that mitochondrial vulnerability in the endotoxic brain conforms to the 
vascular anatomy, together with numerous previous reports of microvascular disturbances in sepsis 
and systemic inflammation (Bowton et al. 1989; Lam et al. 1994; Maekawa et al. 1991; Neviere et 
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al. 1996; Vincent and De Backer 2005) strongly implicate compromised oxygen availability in our 
findings. Therefore, oxygen probe measurements were taken of the cortex of a separate cohort of 
animals. These recordings revealed lower levels of oxygen in the cortices of sick animals compared 
to healthy control mice. Endotoxic animals had the lowest cortical oxygen level at 6 hours, showed 
an increase at 24 hours and a complete recovery at 48 hours after LPS injection. The change in 
cortical oxygenation with systemic inflammation therefore coincided with the increased cortical 
vulnerability of LPS injected mice towards hypoxaemia. 
These findings are in line with evidence suggesting microvascular dysfunction as a leading 
cause of inadequate perfusion and eventually multiple organ dysfunction (Bateman et al. 2001; 
Bowton et al. 1989; Diaz et al. 1998; Drazenovic et al. 1992; Ellis et al. 2002; Gundersen et al. 
1998; Hinshaw 1996; Lam et al. 1994; Levi et al. 1997; Maekawa et al. 1991; Neviere et al. 1996; 
Piper et al. 1996; Schmidt et al. 1997; Vincent and De Backer 2005). Numerous mechanisms can 
lead to inflammation-related changes in perfusion. For example, alterations in endothelial cells 
themselves, such as an increase in adhesion molecule expression or damaged glycocalyx, can lead 
to disordered flow and poor perfusion during sepsis (Bateman and Walley 2005; Cabrales et al. 
2007; Hofmann-Kiefer et al. 2009; Nieuwdorp et al. 2009). Additionally, heterogeneity of the 
microvasculature between and within organs has been repeatedly implicated (Bateman et al. 2003; 
Bateman and Walley 2005; De Backer et al. 2013; De Backer et al. 2014; Ellis et al. 2002; Humer 
et al. 1996; Ince and Sinaasappel 1999; Lam et al. 1994; Piper et al. 1996). Lam et al suggested that 
increased heterogeneity in microvascular perfusion, observed in a normotensive rodent model of 
sepsis, prevented the microcirculation in the muscle from adapting to increases in oxygen demand 
after maximal twitch contraction (Lam et al. 1994). Similarly, it has been suggested that conducted 
vasoconstriction is affected by sepsis which is predicted to have a significant impact on blood flow 
control (Lidington et al. 2004; Tyml et al. 2001). Indeed, the inability to control blood flow and 
tissue oxygenation in sepsis, in response to changes in demand, has been well supported (Astiz et 
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al. 1991; Hartl et al. 1988; Neviere et al. 1996; Sibbald et al. 1991) and is in line with our current 
findings.  
On the other hand, proponents of the cytopathic hypoxia hypothesis of sepsis suggest that 
organ dysfunction originates not from inadequate oxygen provision but rather from mitochondrial 
dysfunction preventing the consumption of readily available oxygen (Fink 1997; Fink 2001; Fink 
2002a; Fink 2002b; Schwartz et al. 1999). This hypothesis originated in part from the inefficiency 
of treatments aiming to enhance oxygen delivery (Gattinoni et al. 1995; Hayes et al. 1994) and from 
findings of metabolic disturbances even in the presence of an apparently sufficient oxygen supply 
(Astiz et al. 1988; Boekstegers et al. 1991; Boekstegers et al. 1994; Crouser et al. 2002a; Crouser 
2004; Rosser et al. 1995; Vandermeer et al. 1995). These data do not however take into account 
that mean arterial blood pressure, whole body oxygenation and cardiac output alone cannot 
determine microvascular perfusion (Bateman and Walley 2005; LeDoux et al. 2000; Neviere et al. 
1996). Instead microvascular heterogeneity and shunting can lead to hypoxic patches in proximity 
to well-oxygenated areas (Bateman et al. 2003; Bateman and Walley 2005; De Backer et al. 2013; 
De Backer et al. 2014; Lam et al. 1994) resulting in an overall high level of oxygenation at the 
systemic and even organ level with small scale abnormalities causing significant tissue dysoxia and 
mitochondrial dysfunction. Indeed therapies aimed at improved microvascular function have shown 
promise in the treatment of sepsis-related dysfunction, including treatment with nitroglycerine 
(Spronk et al. 2002) or nitric oxide donors (Siegemund et al. 2000), together with appropriately 
administered fluid resuscitation.  
Currently our method does not allow us to look at baseline measurement of mitochondrial 
function as preparation quality, laser intensity and imaging depth are too variable to allow the 
detection of subtle changes in mitochondrial redox potential. However, our data suggest that 
perfusion abnormalities result in increased mitochondrial vulnerability in the cortex of endotoxic 
animals as systemic inflammation resulted in less well-oxygenated cortices, and the pattern of 
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mitochondrial vulnerability is spatially related to the cerebral vasculature. These results are in line 
with suggestions of an initially compromised vasculature followed by mitochondrial vulnerability 
and dysfunction due to inadequate oxygenation and cellular dysoxia (Spronk et al. 2005). This 
however, does not exclude additional primary mitochondrial damage due to inflammatory 
mediators. 
3.6.2. Hypothermia as a protection from an 
inflammation-induced energetic challenge 
Our results therefore suggest that even mild systemic inflammation can lead to a supply 
demand imbalance of cortical oxygen that can be revealed during mild hypoxaemia. We therefore 
hypothesised that interventions which reduce metabolism and thereby energy demand (e.g. 
hypothermia (Erecinska et al. 2003; Pernerstorfer et al. 1995)) could offer protection to the cortices 
of endotoxic mice and prevent energetic failure during additional energetic challenges (e.g. 
hypoxaemia). In line with this we found that mild hypothermia, both spontaneous and induced, 
protected animals from hypoxaemia, both in terms of cortical flavoprotein fluorescence and 
survival. Mice that were injected with LPS 6 hours previously and were kept at their spontaneous 
hypothermic temperatures, showed attenuated vulnerability to hypoxaemia (both in terms of 
survival and ‘arterial-halo’ pattern onset) when compared to LPS-injected animals kept at forced 
normothermia (37˚C), indeed almost to the same level of resilience as shown by saline-injected 
control animals. In contrast animals injected with LPS 24 hours prior to flavoprotein imaging were 
not protected from hypothermia. However, this could be attributable to the higher pre-imaging 
mortality rate in the 24 hours normothermic, LPS injected group, as a number of these animals 
could not be assessed. The experimental procedure required continuous anaesthesia for around 1 
hour for the surgery alone, in addition to the imaging duration. Some of the sicker mice, especially 
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at 24 hours post LPS injection, did not survive the surgical anaesthetic depth and were therefore not 
imaged for cortical vulnerability. 
Given the protection afforded by hypothermia to mice injected with LPS at 6 hours we 
further investigated the effect of induced hypothermia (32˚C) on healthy, saline-injected mice. 
Hypothermia was found to be protective (both in terms of preserved flavoprotein fluorescence and 
survival) during hypoxaemia also in healthy mice injected with saline. This further supports the 
protective role of hypothermia during an energetic imbalance and suggests that situations in which 
oxygenation is limited, might benefit from hypothermia or other energy conserving therapies. 
Induced hypothermia (32˚C) also offered protection to animals injected with LPS 6 hours prior to 
assessment. However, this protection was not as effective as spontaneous hypothermia either in 
terms of survival or cortical flavoprotein fluorescence. This result might be due to the variability of 
the disease severity and associated temperatures. In some endotoxic mice the core body temperature 
dropped below 32˚C at 6 hours post injection and these mice were therefore exposed to an increase 
in temperature to 32˚C. Notably lower core body temperatures were also associated with more 
severe clinical signs. These results suggest that the titration of hypothermia treatment is an 
important consideration to ensure adequate protection while reducing any putative negative side 
effects.  
The protective effect of hypothermia was further evident in the preservation of body weight 
associated with more severe hypothermia 24 hours after LPS injection. Animals that were more 
hypothermic showed an attenuated loss in body weight compared with warmer animals of the same 
group, despite severe hypothermia usually being accompanied by more severe clinical signs. These 
data suggest that early onset hypothermia in mice subjected to systemic inflammation may be an 
attempt at energy preservation and protection in the face of a potential energetic imbalance. 
Therefore, forced recovery to normothermia might be detrimental for these animals and could lead 
to excessive energy consumption and an inability to sustain additional energetic insults. A reduction 
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in core body temperature and energy consumption, combined with preservation of body weight and 
slowed heart rate, as reported here, are hallmarks of hibernation which certain strains of mice can 
engage in for the conservation of resources during cold months (Protti and Singer 2006; Singer 
2002). Such findings further support the notion of hypothermia as a possible protective response of 
the energetically challenged organism during endotoxemia.   
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3.7. Limitation and further research 
As mentioned in the introduction, endotoxemia, initiated by a single LPS injection, results 
in a purely inflammatory and not pathogen-driven disease. This simplified model allowed us to 
focus on the inflammatory aspect of systemic inflammation and sepsis while it does not take into 
consideration the complexities of sepsis which can be driven by a various bacteria, viruses or fungi. 
Such factors have strong implications for the applicability of our research into the treatment of 
sepsis in humans. The dual nature of the immune system makes extrapolation to sepsis difficult as 
the pro-inflammatory mediators may be essential in combatting the initial infection and 
hypothermia has been associated with immunosuppression (Hildebrand et al. 2004). Additionally 
it will remain difficult to extrapolate any experimental findings onto a human septic population not 
only because of the varied nature of the pathogens involved in sepsis but also because of the marked 
inter-species variation in the inflammatory response (Bone et al. 1997) as well as the heterogeneity 
in the human patient population exhibiting a number of different underlying conditions (Bone 
1991). 
Additionally it is imperative to optimise the timing of the administration of any treatment, 
especially treatments that can suppress the host immune response, such as hypothermia (Hildebrand 
et al. 2004). Therefore, it is important to consider the different stages that characterise sepsis, 
including an early hyperdynamic, pro-inflammatory phase in which the immune system is both 
combatting the infection and possibly damaging the host, and a subsequent hypodynamic and anti-
inflammatory phase (Bone et al. 1997). The latter phase is considered a compensatory response to 
the initial pro-inflammatory phase and can lead to suppression of the immune response sufficient 
to prevent adequate pathogen elimination and can even lead to immune deficiency (Bone et al. 
1997). Early, titrated hypothermia together with appropriate anti-bacterial/fungal/viral treatment 
might help in preventing an oxygen supply/demand imbalance, while attenuating host damage by 
the immune system and preventing further compensatory anti-inflammatory immune derailment. 
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We note that neither fluid resuscitation was given, nor blood pressure measurements taken, 
so an underlying hypovolaemia in the endotoxic mice may have exacerbated the impact of the 
hypoxaemic insult. Additionally, no neuropathological studies were conducted on the animals 
imaged as the tissue could not be processed following surgery and imaging. Future studies could 
include a histochemical assessment of a separate cohort of animals for the investigation of 
neuropathological correlates. 
Finally, we have not addressed whether the supply/demand imbalance in oxygenation in 
our endotoxic model is related to an inadequate supply, for example through damaged or 
heterogeneous cerebral vasculature (Bateman and Walley 2005; Bowton et al. 1989; De Backer et 
al. 2013; De Backer et al. 2014; Ellis et al. 2002; Humer et al. 1996; Ince and Sinaasappel 1999; 
Lam et al. 1994; Maekawa et al. 1991; Neviere et al. 1996; Piper et al. 1996; Schmidt et al. 1997; 
Vincent and De Backer 2005) or whether it is related to an increase in demand for oxygen, for 
example through increased consumption by mitochondria (d'Avila et al. 2008; Dahn et al. 1995; 
Dawson et al. 1988; Fredriksson et al. 2009; Poderoso et al. 1994; Sjovall et al. 2010; Tanaka et al. 
1982). This could be investigated by a closer analysis of the cerebral vasculature in our model, 
including blood flow assessment (e.g. through laser Doppler measures) and/or vessel perfusion (e.g. 
assessment of number of perfused vessels through injection of fluorescent compounds). 
Additionally mitochondrial function in this model should be investigated in more detail, through 
isolation of mitochondria from the brains of endotoxic mice followed by in vitro assessment of their 
rate of oxygen consumption as well as further in vivo investigation of mitochondrial function that 
could provide baseline measurements and avoid false negatives related to the removal of the 
mitochondria from their pathogenic environment.  
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3.8. Conclusion  
In summary, we observed that mild systemic endotoxemia can lead to increased mortality 
and increased sensitivity of cortical mitochondria (as assessed by flavoprotein fluorescence) to 
additional energetic insult (hypoxaemia). This increased sensitivity to hypoxaemia was 
accompanied by a decrease in cortical oxygenation. Given this imbalance in oxygen supply and/or 
demand, observed in our endotoxic model, a reduction in metabolic rate through, for example 
hypothermia, could attenuate increased mortality and the increased vulnerability of cortical 
mitochondria associated with mild systemic inflammation. These findings suggest that energy 
conserving therapies, like hypothermia, can be beneficial for patients suffering from an oxygen 
supply/demand imbalance as has been reported in sepsis (e.g. reviewed by (Brealey and Singer 
2003)). Such treatment may protect this group of patients from increased vulnerability towards 
other insults that would leave healthy individuals unaffected. However, further research is needed 
to assess the applicability of these findings to a diverse disease in a diverse human population and 
to optimise administration and timing of energy conserving therapies.   
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CHAPTER FOUR 
4. Retinal inflammation 
4.1. Introduction 
Given the association between systemic inflammation and cortical hypoxia, reported in 
chapter 3, together with published reports linking inflammation and hypoxia (Davies et al. 2013; 
Eltzschig and Carmeliet 2011; Karhausen et al. 2005) we sought to investigate the relationship 
between inflammation and hypoxia in other organs and during other inflammatory conditions. 
Therefore, we aimed to assess different models of retinal inflammation in terms of their reliability, 
reproducibility and applicability for the assessment of retinal flavoprotein fluorescence 
longitudinally. 
4.1.1. Why the eye 
The retina and the optic nerve are developmental outgrowths of the brain, originating from 
the neural tube (Silver and Robb 1979). Therefore, the retina and brain share the same tissue 
developmentally, making the retina part of the central nervous system (CNS). Indeed the retina has 
been used repeatedly as a model to characterize and exemplify phenomena implicated in the rest of 
the CNS (Ames and Nesbett 1981; Cordeiro et al. 2004; Dowling and Boycott 1966; Guo et al. 
2010; Mcewen and Grafstein 1968). The eyes have therefore been considered as a “window on the 
brain” (Cordeiro et al. 2004). 
The retina is a highly organized structure with different cell types grouped into different 
layers fed by a relatively simple vascular bed (Figure 4.1.1.1 a and b as well as (Yu and Cringle 
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2001)). Also the mitochondrial distribution within the retina is relatively well compartmentalized 
(Figure 4.1.1.1 c), with the inner and outer plexiform layer, the ganglion cell layer and the inner 
segment containing a high density of mitochondria. Given the limited nature of the retinal 
vasculature (which is constrained due to the need for clear optics (Yu and Cringle 2001)) and highly 
organised mitochondrial distribution, the retina provides a heterogeneous but organised organ in 
terms of oxygen consumption and provision. Indeed, parts of the retina (including the highly 
metabolically active inner segment of the photoreceptors (Yu and Cringle 2001)) are located in 
avascular regions (Figure 4.1.1.1 b). Additionally, it should be noted that the vascular support for 
the outer retina comes primarily from the choriocapillaris. Although this vascular bed is well 
oxygenated it lacks an adequate response to changes in the metabolic need of the photoreceptors 
which may prevent adequate vascular responses during changes in metabolic demand. The 
combination of a metabolically highly active tissue (Ames 1992; Anderson 1968; Toernquist and 
Alm 1979; Wangsa-Wirawan and Linsenmeier 2003) and a poor vascular supply (Yu and Cringle 
2001; Zein et al. 2004) and resulting spatial heterogeneity in tissue oxygenation (Wangsa-Wirawan 
and Linsenmeier 2003) make this model system an excellent one in which to study the relationship 
between inflammation, oxygenation and functional deficits. 
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Figure 4.1.1.1: Retinal structure, vasculature and mitochondrial distribution  
(a) C57bl/6 mouse retina stained with haematoxylin and eosin to exemplify the retinal structure. 
(b) C57bl/6 mouse retina labelled for laminin (component of the basement membrane which 
associates with endothelial cells (Timpl et al. 1979)). Arrows pointing towards retinal vessels. 
(c) C57bl/6 mouse retina labelled with Voltage-dependent anion-selective channel 1 (VDAC 1), 
a mitochondrial marker. NFL, nerve fibre layer; GCL, ganglion cell layer; IPL, inner plexiform 
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, 
photoreceptor layer; RPE, Retinal Pigment Epithelium; CC, choriocapillaris; IS, inner segment 
(of photoreceptors); INL, inner nuclear layer.  
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The retina lacks myelin (Figure 4.1.1.2), and it therefore can provide an interesting model 
in which to distinguish the effects of inflammation from those arising from demyelination. 
Additionally, an absence of myelin provides clear optics through which to image the retina in vivo, 
using confocal microscopy, at greater depths. 
 
Figure 4.1.1.2: The mouse retina and optic nerve stained with haematoxylin and luxol fast 
blue. 
Luxol fast blue straining reveals the lack of myelin in the retina. The myelinated part of the optic 
nerve is stained in blue. Abbreviations: R = retina, MON = myelinated optic nerve. 
4.1.2. Endotoxin induced uveitis (EIU) 
Uveitis is a generalised inflammation of the highly vascular and pigmented uvea which is 
composed of the iris, the ciliary body and the choroid, but with frequent spreading of the 
inflammation to the retina and vitreous (Rothova et al. 1992). It is considered to be the most 
common form of ocular inflammation with an incidence of 17-52 cases per 100,000 people 
(Wakefield and Chang 2005). Uveitis is associated with a number of diseases including MS (Zein 
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et al. 2004), juvenile rheumatoid arthritis (Wolf et al. 1987), inflammatory bowel disease (Orchard 
et al. 2002), Reiter’s syndrome (Kiss et al. 2003) and others (Rothova et al. 1992). 
As mentioned before, LPS are components of the cell walls of Gram-negative bacteria. 
Upon injection of LPS, this endotoxin binds to receptors on for example microglial cells, such as 
TLR4 (Chow et al. 1999; Henneke and Golenbock 2002), initiating an inflammatory cascade which 
includes the recruitment of further immune cells, secretion of cytokines and formation of NO. When 
injected systemically (intravenous, intraperitoneal or foot pad administration) or locally (into the 
vitreous of the eye) LPS can elicit strong, dose-dependent inflammatory reactions in the eye, termed 
endotoxin-induced uveitis (EIU) (Devos et al. 1994; Forrester et al. 1980; Hoekzema et al. 1992; 
Rosenbaum et al. 1980). EIU involves breakdown of the blood retinal barrier (Koizumi et al. 2003), 
infiltration of inflammatory cells (Hayashi et al. 1996), and a reduction in the A and B waves of the 
electroretinogram (ERG) (Del Sole et al. 2008; Franco et al. 2008), and can result in damage ranging 
from the cornea (Aslan et al. 2007), and anterior chamber (Allen et al. 1998) to the retina (Franco 
et al. 2008; Sasaki et al. 2009). 
4.1.3. Visual defect in experimental 
autoimmune encephalomyelitis (EAE) 
Experimental autoimmune encephalomyelitis (EAE) is a frequently used model of MS and 
is induced by immunisation with a myelin antigen, derived from homogenized CNS tissue or myelin 
proteins, in adjuvant ((in)complete Freud’s adjuvant, serving as an immunopotentiator). This 
immunisation results in an inflammatory, demyelinating disease of the CNS, with variable 
characteristics and time course, depending on the animals and myelin epitope used. Typically, 
animals will show ascending paralysis and inflammation of the CNS, primarily in the spinal cord 
but also in the brain and optic nerve, together with demyelination and axonal damage (Rao and 
Segal 2004). Several different proteins have been used to induce EAE, including myelin basic 
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protein, proteolipid protein and myelin oligodendrocyte glycoprotein (MOG), in several different 
species, including mice, rats, guinea pigs and non-human primates (Rao and Segal 2004). 
MOG is a protein believed to be involved in the pathogenesis of MS (Derosbo et al. 1993; 
Quarles 2002; Sun et al. 1991). MOG is preferentially found on the outside of CNS myelin sheaths 
(Quarles, 2002) and this distribution means that it is more strongly represented in tissues where the 
surface area to volume ratio is greater, such as the optic nerve. The exposed location of MOG could 
make it an important antigen in possible autoimmune diseases such as MS (Genain and Hauser 
2001; Iglesias et al. 2001; t'Hart et al. 2000). Indeed it is possible to induce EAE in rodents by 
injecting MOG subcutaneously (Stefferl et al. 1999). For example it can be used to induce EAE in 
female Brown Norway (BN) rats resulting in a more pronounced visual involvement compared to 
immunisation of other strains (Meyer et al. 2001; Storch et al. 1998). Therefore, the induction of 
EAE via a subcutaneous injection of MOG in female BN rats results in a fulminant disease course 
which mimics the opticospinal form of MS (Collongues et al. 2012) 
4.1.4. Age-related macular degeneration 
(AMD) and factor H transgenic mice 
As mentioned in the introduction (chapter 1) ageing and its associated pathology are often 
characterised by neuroinflammation (Anderson et al. 2002; Buschini et al. 2011; Mcgeer et al. 2005; 
Mcgeer and Sibley 2005). The complement system, an essential part of the innate immune-
inflammatory reaction, has been implicated in several inflammatory CNS diseases (Barnum 2002; 
Van Beek et al. 2003) and specifically in AMD (Coffey et al. 2007; Hageman et al. 2005; Hollyfield 
et al. 2008). AMD leads to the degeneration and damage of the central part of the retina and is the 
leading cause of visual loss in developed countries (Taylor and Keeffe 2001). 
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More specifically, complement factor H (CFH) deficiency has been associated with AMD 
(Coffey et al. 2007; Edwards et al. 2005; Hageman et al. 2005; Klein et al. 2005), with a link made 
between the AMD phenotypes and polymorphisms in Factor H encoding genes in humans (Edwards 
et al. 2005; Hageman et al. 2005) and CFH deficiency in mice resulting in visual defects that mimic 
certain aspects of the human disease (Coffey et al. 2007). CFH is a regulator of the alternative 
pathway of the complement system, primarily involved in inhibiting complement activation in 
response to host cells, thereby preventing autoimmunity. CFH recognizes heparin or sialic acid on 
host cells, and binds to any C3b present on such cells, thereby inactivating it. Therefore, a lack of 
Factor H can lead to excessive activation of the complement cascade, production of pro-
inflammatory proteins and potentially the loss of host cells (Alexander et al. 2005). And indeed, 
aged CFH-/- mice show enhanced deposits of C3 on the basement membrane which also extend into 
the RPE and even into the outer retina, revealing excessive inflammatory activity in the retinas of 
aged CFH-/- mice (von Leithner et al. 2009). 
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4.2. Hypotheses 
3) High levels of retinal inflammation result in functional deficits, as assessed by ERG 
recordings, and retinal hypoxia, as assessed by the intravenous probe, hypoxyprobe 
4) The endogenous fluorescence of flavoproteins can be used to assess mitochondrial 
redox state in vivo in the retinas of anaesthetized mice 
4.3. Aims and objectives 
The aim of this chapter is to explore models of retinal inflammation, comparing their utility 
and reproducibility as well as their relationship with hypoxia. Additionally, we aim to test the use 
of flavoprotein fluorescence as a marker of mitochondrial redox potential in the retinas of 
anaesthetised mice. 
Here we investigate four methods to induce retinal inflammation. The models include the 
classic induction of EAE in Brown Norway rats (a form of EAE that significantly involves the 
visual pathway), endotoxin-induced uveitis (intravitreal and systemic injection of LPS), and the use 
of transgenic factor H knockout mice (CFH-/-; a model of AMD).  
Using histochemical markers of hypoxia and inflammation together with 
electrophysiological readouts of retinal function we will explore the relationship between 
inflammation, visual function and hypoxia in the retina.  
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4.4. Methods 
4.4.1. Hypoxyprobe injections 
Hypoxyprobe, a marker of hypoxia (pO2 ≤ 10mmHg), was injected i.p. at a dose of 
60mg/kg. In the absence of oxygen, hypoxyprobe becomes reductively activated and binds to 
sulfhydryl-containing macromolecules to form adducts which can be detected 
immunohistochemically. 
Mice were kept in different ambient air conditions. Eight mice were kept in 10% oxygen 
and 90% nitrogen and two were kept in room air. Half of the mice from each group were culled 
after just one hour post injection and the other half after 4 hours. The cardiac perfusion (see below) 
was conducted under the same oxygenation as used for the experimental manipulation. 
4.4.2. Flash Electroretinograms 
To conduct the flash ERGs the animals were dark adapted for up to 60 minutes and 
anaesthetised with a mixture of ketamine (Ketaset, containing 100mg/ml ketamine, Animal Health 
Ltd, USA) and xylazine (Xylacare, containing 20mg/ml xylazine base, Animalcare Ltd, UK). 
Viscotears (BR Pharmaceuticals, USA) were applied to prevent corneal drying. The core body 
temperature was maintained at 37˚C with the use of a homeothermic heating mat and rectal probe. 
The recording electrode was formed from a monofilament platinum wire twisted into a coil and 
placed onto the cornea with a ‘ground’ and reference electrode (hypodermic needles) inserted 
subcutaneously in the back and scalp respectively. All adjustments to the recording arrangements 
were conducted under red light illumination.  
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4.4.3. In vivo retinal imaging 
B6.Cg-Tg(Thy1-YFPH)2Jrs/J mice expressing yellow fluorescent protein (YFP) in a subset 
of neurons, including 10-30% of ganglion cells (http://jaxmice.jax.org/strain/003782.html), or their 
YFP negative litter mates, were anaesthetised with ~2% isoflurane in room air and subsequently 
placed on a homeothermic heating mat to maintain their rectal temperature at 37˚C. The eyes were 
kept moist and protected with Viscotears and the skin surrounding the eye was removed. The 
underlying bone and muscle were cleaned with saline and dried. A custom made titanium ring, 
attached to a stable base, was affixed to the skull surrounding the eye, using dental cement 
(Contemporary Ortho-Jet Powder, USA) mixed with cyanoacrylate glue (Loctite, Henkel Ltd., UK). 
After drying of the dental cement a circular coverslip (~10mm diameter) was placed over the cornea 
and stabilized and sealed using petroleum jelly (Vaseline, Unilever, UK). Following surgery, the 
mice were moved to a custom-made stage for confocal microscopy, and the inspired oxygen 
concentration was varied, as indicated, by changing the mixture of oxygen and nitrogen delivered 
via a nose cone. 
4.4.4. Disease models 
4.4.4.1.  Experimental autoimmune encephalomyelitis 
(EAE) 
Seven female BN rats were anaesthetised with isoflurane (IsoFlo, Abbott Laboratories, 
USA) and injected subcutaneously, with 100 µl of complete Freund’s adjuvant (CFA) (Sigma-
Aldrich, USA) containing 1mg/ml heat-killed and dried Mycobacterium tuberculosis with 100µg 
recombinant myelin oligodendrocyte glycoprotein (rMOG). ERG recordings were taken serially 
and the rats were weighed and assessed for clinical signs daily. Rats were scored in relation to the 
criteria in table 4.4.4.1.1. A cumulative score for each symptom (1 point per symptom) was 
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assigned. Additionally, a total score was given to each animal which consisted of the sum of all 
scores across the assessment time period. This score therefore took into account the severity and 
the rate of the disease progress. 
Tail tip weakness 
Tail weakness 
Tail paralysis 
Abnormal gait 
Abnormal toe spreading 
Unilateral hind limb weakness 
Bilateral hind limb weakness 
Unilateral hind limb paralysis 
Bilateral hind limb paralysis 
Moribund 
Table 4.4.4.1.1: Clinical disease scoring of EAE rats. 
Each symptom is assigned one point with a cumulative 
score assigned daily. 
During the peak of the disease (within 4 days of disease onset) rats were injected 
intravenously (via the saphenous vein) with hypoxyprobe (60 mg/kg) and left for 4 hours before 
intracardiac perfusion fixation.  
4.4.4.2. Intravitreal LPS 
Lipopolysaccharide (LPS) from Salmonella abortus equi (Sigma-Aldrich, USA) was used 
for intravitreal injections into mouse eyes. Twenty-one C57bl/6 mice were anaesthetised with 
ketamine/xylazine as before and a glass needle attached to a microsyringe, partly filled with mineral 
oil, was used to inject 0.5µl of variously diluted LPS or saline (control). 
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Dose trial: Six C57bl/6 mice were injected intravitreally with different doses of LPS (10ng, 
100ng or 500ng) into one eye, while the other eye acted as a saline-injected control. ERG recordings 
were taken before termination 24 hours after intravitreal LPS injection. 
Time trial: Control eyes were injected as above, and 40ng of LPS was injected into the 
contralateral eye. The animals were then injected i.p. with hypoxyprobe and ERG recordings were 
taken before termination 8, 24, 48, 72 hours or 7 days post injection (n=15, 3 per group). 
4.4.4.3. Systemic LPS 
LPS from Escherichia coli (Sigma Aldrich, USA) was dissolved in sterile saline and 
injected i.p. at various concentrations (from 1mg/kg – 5mg/kg) at a volume of 10ml/kg. Saline was 
injected in the same way. Following the injection the peritoneum was gently massaged to aid the 
distribution of the injection. Eight C57bl/6 mice were culled 10 hours after an i.p. injection of saline 
or LPS (1mg/kg, 3mg/kg or 5mg/kg, n = 2 per group) while a further 8 (same groups) were culled 
24 hours after the injections.   
4.4.4.4. CFH-/- mice 
Twenty C57bl/6 mice (10 mice at 5-6 weeks and 10 mice at 16-24 months) and twenty-five 
CFH-/- mice on a C57bl/6 background (15 mice at 4 weeks and 10 mice at 14-15 months) were 
injected with hypoxyprobe i.p. and culled 2 hours post injection by cervical dislocation or perfusion. 
All animals were purchased from Harlan, with the exception of the CFH-/- mice, which were 
provided by Matthew Pickering at Imperial College London. All animals were housed in a 12 hour 
light/dark cycle with food and water ad libitum. All experiments were performed in accordance 
with the UK Home Office Animals (Scientific Procedures) Act (1986). 
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4.4.5. Perfusion and fixation 
Culmination of the experiments occurred either at an experimental endpoint or when the 
animal was suffering or could not reach food or water. Animals were culled via cervical dislocation 
or anaesthetised and culled via cardiac perfusion. For the cardiac perfusion, heparinised buffered 
saline was used to rinse away the blood from the vasculature which was followed by fixation with 
4% paraformaldehyde (PFA) in phosphate buffered saline (PBS). The tissue was harvested and post 
fixed overnight in 4% PFA. It was then cryoprotected in 30% sucrose with 0.02% sodium azide, 
dissected, embedded in OCT (Optimal Cutting Temperature, Tissue Tek, UK) and frozen in dry 
ice. The tissue was then cut into 10µm thick sections and stored at -20°C until further use.  
4.4.6. Immunohistochemistry 
Fluorescent labelling of compounds was largely conducted in a similar fashion: after 
blocking with the appropriate serum (5%, Table 4.4.6.1, Vector Laboratories, USA) for more than 
30 minutes the slides were incubated with the appropriate primary antibody diluted in 5% serum 
overnight at 4°C (Table 4.4.6.1). After a thorough wash the slides were incubated in a secondary 
antibody conjugated to a fluorophore diluted in 5% serum at room temperature for 1 hour. Slides 
were washed and mounted with Vectashield mounting medium (Vector Laboratories, USA) and 
sealed with nail varnish. They were then stored at 4°C until imaging.  
To label slides using DAB (3,3'-diaminobenzidine) the slides were initially incubated with 
0.3% hydrogen peroxide dissolved in methanol to saturate and thereby inactivate endogenous 
peroxidase activity. Following several washes slides were incubated with sodium borohydride twice 
for 5 minutes to uncover antigen by blocking free aldehydes. Following this, non-specific secondary 
antibody binding was blocked using the appropriate 5% serum or casein (only for hypoxyprobe 
antibody on rat tissue; see Table 4.4.6.1) for more than 30 minutes. Incubation of the primary 
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antibody followed, overnight at 4˚C. On the following day stringent washes preceded incubation 
with the appropriate biotinylated secondary antibody for one hour at room temperature. After this 
was washed off, slides were incubated with an avidin-biotin complex (Vectastain ABC kit, Vector 
Laboratories, USA) for thirty minutes. Following a further thorough wash the slides were briefly 
incubated with DAB which reacts with peroxidase enzymes included in the ABC kit to form a stable 
brown deposit. Slides were dehydrated in a series of alcohols and xylene and mounted with DPX 
(dibutyl phthalate xylene) mounting medium (VWR, UK) to be stored at room temperature. 
1° antibody 
Dilution 
1° 
Source Company Serum 
2° 
antibody 
Dilution 
2° 
Anti- ED1 1:200 
Mouse, 
monoclonal 
Sigma Aldrich Horse 
Horse 
anti-
mouse 
1:200 
Anti-IBA1 1:500 
Rabbit, 
polyclonal 
Wako Goat 
Goat anti-
rabbit 
1:200 
Anti-
Hypoxyprobe 
(for mouse 
tissue) 
1:200 
Rabbit, 
polyclonal 
HypoxyprobeTM Goat 
DAKO 
secondary 
anti-rabbit 
NA 
Anti-
Hypoxyprobe 
(for rat 
tissue) 
1:200 
Mouse, 
monoclonal 
HypoxyprobeTM Casein 
Horse 
anti-
mouse 
1:200 
Anti-MHC 
class II 
1:250 
Mouse, 
monoclonal 
Abcam Donkey 
Donkey 
anti-
mouse 
1:500 
Anti-iNOS 1:200 
Rabbit, 
polyclonal 
BD transduction 
labs 
Goat 
Goat anti-
rabbit 
1:500 
 
Table 4.4.6.1: Primary antibodies used and their dilutions, specifications and further 
protocol information. 
DAB labelling of hypoxyprobe in mouse tissue involved the use of a DAKO blocking kit. 
Here the slides were initially agitated with 3% hydrogen peroxide in methanol after which citric 
acid (1:10 dilution, DAKO, Denmark) was used for antigen retrieval. Blocking was conducted with 
the DAKO blocking solution (Protein block, serum free) followed by incubation with the primary 
antibody (diluted 1:200 in 5% normal goat serum) overnight at 4°C. After a thorough wash the 
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slides were incubated with the secondary antibody (DAKO polymer HRP anti-rabbit). After 1 hour 
the DAKO substrate chromogen was dropped onto the slides and left for 3 minutes after which the 
slides were submerged in deionised water, dehydrated through a series of alcohols and xylene and 
mounted with DPX. The slides were subsequently stored at room temperature.  
4.4.7. Image acquisition 
Fluorescent image capture was conducted with the LSM 5 Pascal confocal microscope 
(Zeiss, Germany). Light microscopy was conducted with an Axiophot light microscope (Zeiss, 
Germany) including a Nikon D300 camera (Nikon, USA). Illumination conditions were stable 
throughout image acquisition. 
4.4.8. Image quantification and statistical 
analysis 
All image quantification was conducted using Fiji/ImageJ Version 1.48v (NIH, USA). 
Three analysis techniques were used: fluorescence intensity, particle count and percent area of 
positive labelling. The fluorescence intensity quantification was conducted through a Fiji/ImageJ 
plugin and particle counts were done manually. Percent areas of positive labelling involved the 
development of a threshold, which was chosen to be the mean intensity of an appropriate control 
image plus two standard deviations and everything above this threshold was considered positive 
labelling. This threshold then allowed the determination of the percentage of the selected area 
covered by positive labelling.  
Statistical analysis was conducted via IBM SPSS Statistics 20. Standard Student t-tests and 
analyses of variance (ANOVA) were conducted in which the p-value cut off for statistical 
significance was 0.05.  
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4.5. Results 
4.5.1. Electroretinograms 
In order to optimize ERG recordings we investigated factors that could potentially 
influence the amplitude of the recorded flash ERG. These include stimulus intensity, dark 
adaptation, interpulse duration, electrode placement and the amount of Viscotears used. For 
simplicity averaged traces of the two eyes of different mice within the same group will be displayed, 
as there is limited variation between animals or between the two eyes of the same animal (Figure 
4.5.1.1). 
 
Figure 4.5.1.1: Example traces of both eyes of two dark adapted mice subjected to 58mA 
light pulse stimuli. 
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An increase in stimulus intensity increased the amplitude and decreased the latency of the 
ERG (Figure 4.5.1.2 a). It is possible that the increase in latency with decreased stimulus amplitude 
was a function of the stimulus arrangement, which might have had a delayed flash response at lower 
amplitudes. Additionally, it is evident that a longer dark adaptation of 1 hour resulted in a greater 
ERG amplitude compared to 30 minutes dark adaptation or 30 minutes light adaptation, while 30 
minutes red light adaptation had approximately the same effect as 30 minutes dark adaptation 
(Figure 4.5.1.2 b). This allowed us to manipulate mice under red light without disturbing the dark 
adaptation. Additionally, a longer interpulse period resulted in more reproducible ERGs with 
greater amplitudes (Figure 4.5.1.2 c and d). This might be a result of light adaptation after frequent 
and repeated stimulation. The increased time span used in the 4 second interpulse periods, compared 
to the 1 second interpulse period, resulted from maintaining the number of stimulus averages 
consistent. Finally neither electrode placement (Figure 4.5.1.2 e) nor the amount of Viscotears used 
(Figure 4.5.1.2 f) seemed to have a significant effect on the ERG shape.  
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Figure 4.5.1.2: An investigation of the factors affecting ERG amplitude and latency.  
The effect of stimulus intensity (a) and dark adaptation (b) on ERG amplitude. The effect of interpulse 
period duration on ERG amplitude and stability (c) and (d). A series of ERG recordings with a 1 
second interpulse period (c). ERG recordings with a 4 second interpulse period (d). ERGs of mice 
subjected to variations in electrode placement (e). The effect of Viscotear application on ERG 
amplitude (f); Maximum refers to the maximum possible usage of Viscotears and minimum refers to 
the least possible usage (without drying of the cornea). Each record is an average of 100 traces of 2 
mice (mean of 4 eyes) with the exception of the electrode placement eyes which averaged of n = 3. 
Given the above findings, any future recordings were presented in scotopic conditions, 
including dark adaptation, while the stimulus itself was relatively bright, with a 4 second inter pulse 
period, resulting in a response driven both by the rod and the cone pathways (Clark and Kraft 2012). 
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4.5.2. Hypoxyprobe labelling in the hypoxic 
murine retina 
To characterise the use of hypoxyprobe as a marker of retinal hypoxia, we assessed the 
changes in labelling between mice maintained in room air, and mice placed into a reduced-oxygen 
environment (10% O2). 
Retinas of mice injected with hypoxyprobe and subjected to a fraction of inspired oxygen 
(FiO2) of 10% for 4 hours are more strongly labelled compared with retinas subjected to 
hypoxyprobe and room air for 4 hours (Figure 4.5.2.1), suggesting that hypoxyprobe labelling is 
sufficient to detect a reduction in oxygen concentration for 4 hours. Also 1 hour after hypoxyprobe 
injection and hypoxia, the retina exhibits more labelling as compared to a room air control, despite 
a reduced difference in labelling between hypoxic and normoxic retinas as compared to the 4 hour 
condition.  
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Labelling with DAB highlighted areas of intense hypoxia in the retina of hypoxaemic mice 
(Figure 4.5.2.1 a arrows). Such areas can be mainly seen in the inner plexiform layer but also the 
inner segment of the photoreceptors (though less consistently).  
 
Figure 4.5.2.1: Hypoxyprobe labelling in the retinas of hypoxaemic mice. 
(a) Retinas of mice injected with hypoxyprobe and kept in room air (21% O2) or 10% oxygen for 1 
hour or 4 hours. The white arrows indicate areas with intense hypoxyprobe labelling. Abbreviation: 
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer 
plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer; IS, inner segment (of 
photoreceptors); OS, outer segment (of photoreceptors). (b) Quantification of the amount of 
labelling (average intensity from GCL to IS) displayed as mean ± SEM.  
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The difference in labelling between hypoxic and normoxic retinas, originates mainly from 
the inner retina. Indeed we found that there is a ~23% increase in hypoxyprobe labelling in the 
ganglion cell layer of hypoxic mice compared to normoxic mice and an approximately 19% increase 
in the inner plexiform layer as compared to a ~4% increase in the outer plexiform layer (data not 
shown). 
4.5.3. EAE induction in Brown Norway rats 
4.5.3.1. Clinical disease characterisation 
Eight of eleven rats immunised with rMOG developed clinical disease characteristics. 
However, only five of them developed a quantifiable neurological deficit, ranging from tail tip 
weakness to hind limb paralysis, while three rats had severe vestibular problems, balance issues and 
lethargy. Due to the severity of these clinical signs they were given a score of 7-9, depending on 
the state of the animal. The incidence of clinical disease in the ERG control group (no ERG) was 
100% (5 of 5) while only 50% of rats that were examined by ERG developed clinical deficits (3 of 
6) by 29 days post immunisation. None of the CFA control rats showed any clinical deficits. 
4.5.3.2. (Immuno)histochemical characterisation 
Microglial morphology was assessed through IBA1 labelling. Microglia were divied into 
three groups of increasingly amoeboid morphology (Figure 4.5.3.2.1), based on the classification 
used in Desai (2013). Type I consisted of microglia with a ramified morphology with only the 
processess being labelled and visible. Type II microglia consisted of thickened processess and 
enlarged, clearly visible cell bodies. Type III microglia were amoeboid shaped with almost all 
processes retracted and only a rounded cell body being evident. Such changes in morphology have 
frequently been used as early indictaors of microglial activation (e.g. (Opie et al. 2012; Zhang et al. 
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2005), for review see for example (Streit et al. 1988) and figure 1 in (Hanisch and Kettenmann 
2007)). 
 
Figure 4.5.3.2.1: Microglial morphology as assessed by IBA1 labelling.  
Microglia were divided into three groups (modified from (Desai 2013)). Type I microglia 
consisted of fine processes without cell body. Type II microglia consisted of enlarged processes 
and thickened cell bodies while type III microglia consisted of enlarged and rounded cell bodies 
with most processes completely retracted. Scale bar = 10µm. 
Retinas and spinal cords of rats were assessed for the percentage of each microglial subtype. 
Asymptomatic and control rats exhibited less microglial activation compared to symptomatic rats 
in the grey matter of the spinal cord (Figure 4.5.3.2.2 a and c). However, these differences are not 
significant (p ≥ 0.05 after Bonferroni correction). In contrast, the retinas of rMOG immunised rats 
show greater microglial activation as compared to control rats (Figure 4.5.3.2.2 b and d, p ≤ 0.05 
after Bonferroni correction when comparing type I and II microglial activation across groups). The 
microglial activation in the retina is limited to the inner retina with most activation evident in the 
ganglion cell layer (Figure 4.5.3.2.2 b).  
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Figure 4.5.3.2.2: Microglial activation in the spinal cords (a) and (c) and retinas (b) and 
(d) of rats with EAE and controls.  
Grey matter of spinal cords (a) and retinas (b) of control rats, asymptomatic rats and rats with 
clinical signs labelled for IBA1, indicating microglial morphology. Scale bar = 50µm. 
Quantification of microglial activation in the spinal cord grey matter (c) and retinas (d) of EAE 
and control animals. Data represented as percentage of types of microglial activation categories 
as defined in Figure 4.5.3.2.1. Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform 
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. 
 
Histochemical labelling of ED1/CD68 (indicating the presence of phagocytic microglia or 
macrophages) revealed that optic nerve inflammation occurred even in animals lacking clinical 
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deficit, as assessed by tail and hind limb weakness/paralysis (Figure 4.5.3.2.3, in line with 
microglial morphology changes in asymptomatic retinas, Figure 4.5.3.2.2 b and d). This optic nerve 
inflammation was absent in adjuvant controls (Figure 4.5.3.2.3). No ED1 labelling could be found 
in the retina (data not shown).  
There was a positive relationship between ED1 coverage in the optic nerve and the score at 
perfusion (p ≤ 0.001, Spearman’s rank correlation coefficient) as well as the total score (p ≤ 0.001). 
There is also a significant difference between ED1 coverage in the optic nerves of control and 
symptomatic rats (p ≤ 0.01, two-tailed t-test) while there is no relationship between ED1 coverage 
and the difference in ERG amplitude before and after symptom onset (p ≥ 0.05, Spearman’s rank 
correlation coefficient), (Figure 4.5.3.2.3).  
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Figure 4.5.3.2.3: ED1 positive cells in the optic nerve of control, asymptomatic and 
symptomatic rats.  
Scale bar = 50µm. Graphs: relationship between ED1 positive cell coverage and score at 
perfusion, total score, ERG amplitude difference before and after symptom onset and grouping. 
Data displayed as individual data points (grey diamonds) and means of groups (black lines). ** 
= p ≤ 0.01. 
There is a weak relationship between the clinical disease and hypoxyprobe labelling in the 
retinas of EAE rats (Figure 4.5.3.2.4) but this is not statictically significant (p ≥ 0.05). 
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Figure 4.5.3.2.4: Hypoxyprobe labelling in the rat retina in control animals and animals 
induced with EAE.  
(a) Quantification of hypoxyprobe associated DAB intensity in the retinas of rats in the different 
groups. (b) Sample images of hypoxyprobe labelling in the rat retina in the three groups. Scale 
bar = 50µm. (c) Relationship between hypoxyprobe labelling in the retina and the clinical score 
of the rat at perfusion and the total score of the animal. All p ≥ 0.05. 
There is no relationship between hypoxyprobe labelling in the retina and clinical score at 
perfusion or total score (defined by summing the daily scores of the animals until perfusion, Figure 
4.5.3.2.4 c). This latter evaluation takes into account the score of the animal as well as the speed 
with which the animal succumbs to disease. Additionally there is no statistically significant 
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relationship between hypoxyprobe labelling and the level of inflammation (as assessed by 
microglial activation, data not shown). 
4.5.3.3. Electroretinogram characterisation 
As evident from the ERG records (Figure 4.5.3.3.1), the amplitude of both the A and the B 
wave in animals showing motor deficits is decreased relative to the other groups (Figure 4.5.3.3.1 
a) when measured on the day of culling, as well as relative to the ERG amplitude before 
immunisation with rMOG (Figure 4.5.3.3.1 b and c).  
 
Figure 4.5.3.3.1: ERGs collected in response to a 10ms flash of 58mA.  
(a) A comparison of the average ERG traces of symptomatic, asymptomatic and control rats on the day 
of culling. (b) Comparison of the ERG traces of symptomatic rats before injection and 24-72 hours 
after developing symptoms (day of culling). (c) The peak-to-peak amplitude in the three groups of rats, 
before injection and 24-72 hours after symptom onset (day of culling). Displayed as mean ± SEM. All 
p ≥ 0.05 
128 
 
4.5.4. Intravitreal LPS injections 
4.5.4.1. Concentration trial 
One of the mice injected with 500ng LPS had to be excluded as the injection was not 
sufficiently accurate. None of the mice showed any obvious clinical symptoms. 
4.5.4.1.1. (Immuno)histochemical characterisation 
A haematoxylin and eosin (H&E) stain (Figure 4.5.4.1.1.1, top panel) reveals that saline 
injections caused no detectable pathology but that the eyes of the same animals, injected with 
various doses of LPS, show a dose dependent response, ranging from cellular infiltration in the 
vitreous along the surface of the retina, to haemorrhage and complete retinal disorganisation. 
Labelling for iNOS and major histocompatibility complex class II (MHCII) revealed that these 
infiltrating cells show inflammatory characteristics (Figure 4.5.4.1.1.1). However, it seems that 
iNOS only plays a significant role when complete retinal disorganisation is achieved. MHC class 
II bearing cells on the other hand seem to be present at each concentration of LPS near the surface 
of the retina and also further inside the retina after a 500ng injection of LPS (Figure 4.5.4.1.1.1). 
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Figure 4.5.4.1.1.1: Inflammation in retinas injected with 10ng, 100ng or 500ng LPS in 
one eye with the other eye acting as a saline control.  
Top panel: H&E stain. Lower panel: iNOS (green) and MHCII (red) immunofluorescence. 
Scale bar = 200µm 
There does not seem to be much infiltration of cells into the retina at either 10ng or 100ng 
LPS injections. Instead cells tend to localise around the interface between retina and vitreous. 
However, at an injection of 500ng of LPS the retina becomes completely disorganised with cellular 
infiltration and severe haemorrhage. Haemorrhage also occurred to a lesser extent in some of the 
mice injected with 100ng. 
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4.5.4.1.2. Electroretinogram characterisation 
LPS had a dose dependent effect on the ERG amplitude (Figure 4.5.4.1.2.1). 
 
Figure 4.5.4.1.2.1: ERGs collected 24 hours after injection of various doses of LPS into the 
vitreous of one eye, with the other eye acting as a saline control.  
Stimulus amplitude = 58mA. n=5. (a) averaged traces; (b) individual traces. 
As can be seen, a higher injection dose led to a greater difference in ERG amplitude 
between the LPS injected eye and the control eye, with 500ng of LPS eliminating any ERG signal. 
However, this could also be due to haemorrhage, evident at higher doses of LPS, which could 
prevent the penetration of light onto the retina during recording of the ERG. 
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4.5.4.2. Time trial 
Given the findings of the concentration trial it was decided that a time trial of intravitreal 
LPS injections should be conducted with 40ng of LPS, avoiding concentrations that cause severe 
haemorrhage but administering a high enough dose to provide a strong inflammatory response. 
4.5.4.2.1. (Immuno)histochemical characterisation 
Control eyes injected with saline show no abnormalities or infiltrating cells. Eyes injected 
with 40ng of LPS show cell infiltration after 24 hours with some eyes showing complete 
disorganisation after 24 hours, 3 days and 1 week, including haemorrhage and severe pathology. 
The haemorrhage may have been responsible for some of the severely attenuated ERG recordings, 
particularly at 3 days post injection. 
The level of disorganisation of the retina and immune cell infiltration seemed not to be 
related to a particular time point (with the exception that no overt infiltration was evident at 8 hours 
post LPS injection, as assessed with H&E labelling) as the variation between mice of the same 
group is unexpectedly large (Figure 4.5.4.2.1.3 a). It is possible that extreme retinal disorganisation 
may be the result of slight mechanical damage to the retina during injection. However, given that 
none of the saline injected-eyes show any form of disorganisation it is likely that mechanical 
damage to the retina needs to be combined with LPS to cause severe retinal disorganisation.  
As there was greater variation within groups compared to between groups of varying time 
points (Figure 4.5.4.2.1.3 a) the data will be presented in terms of inflammatory severity. 
Inflammation was rated by a blinded observer (based on H&E labelling) and grouped into retinas 
showing no, mild, moderate and severe disorganisation. 
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Severe retinal damage, including disorganisation of the retina and haemorrhage, led to 
iNOS upregulation (Figure 4.5.4.2.1.1). MHC class II molecules however, were also involved in 
less severe pathology, being located mainly along the retinal/vitreal interface (Figure 4.5.4.2.1.1). 
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Figure 4.5.4.2.1.1: Inflammation in retinas of mice injected with 40ng of LPS into one eye and 
saline into the other and culled at various time points (see methods).  
Retinas of eyes injected with LPS were divided into no-, mild-, moderate-, and severe inflammatory 
cell infiltration by a blinded observer. 1st panel: H&E stain. 2nd panel: iNOS (green) and MHCII (red) 
immunofluorescence. 3rd panel: Morphological microglial and macrophage label (IBA1), 4th panel: 
hypoxyprobe label. 
Additionally, it can be seen that even in the absence of observable inflammatory cell 
infiltration (as determined by H&E staining) microglial morphology in the retina changes in 
response to an intravitreal LPS injection into a more activated phenotype (Figure 4.5.4.2.1.1). As 
the inflammation becomes more severe the microglial morphology changes from a ramified 
quiescent state to a more amoeboid and activated state (Figure 4.5.4.2.1.2a and also see Figure 
4.5.3.2.1 for microglial morphological characterisation). Microglial activation does not only occur 
before noticeable inflammatory cell infiltration but also shortly after injection of LPS (8 hours after 
injection) (Figure 4.5.4.2.1.2 b). 
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Figure 4.5.4.2.1.2: Microglial activation after intravitreal LPS injections.  
(a) Quantification of microglial activation pattern grouped by the amount of inflammatory cell 
infiltration, as determined by blinded assessment of H&E labelling. (b) Upper panel: 
representative image showing enhanced microglial activation in retinas 8 hours after LPS 
injection as compared to saline-injected counterparts, despite an absence of inflammatory cell 
infiltration (H&E: lower panel). Scale bar = 50µm. 
Also hypoxyprobe labelling increases with intravitreal LPS injections compared to saline 
injections (Figure 4.5.4.2.1.1 and Figure 4.5.4.2.1.3 c). There is a possibility that the retinas which 
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showed severe damage and disorganisation became detached from the supporting choriocapillaris. 
This could lead to reductions in oxygenation unrelated to LPS induced inflammation. Therefore, 
these animals were removed from the analysis. Nevertheless, the paired sample t-test revealed a 
significant difference between the labelling intensity of retinas of LPS-injected eyes when at least 
some inflammatory cell infiltration is present (as assessed by H&E labelling), and their vehicle-
injected controls (p ≤ 0.05). 
 
Figure 4.5.4.2.1.3: iNOS and hypoxyprobe labelling after intravitreal LPS injections. 
iNOS (a) and (b) and hypoxyprobe (c) labelling sorted by disease duration (a) and level of 
inflammatory cell infiltration, as assessed by H&E labelling by a blinded observer (b) and (c) (a) 
– (c) p ≥ 0.05. Relationship between hypoxyprobe and iNOS labelling, Shapiro-Wilk test, p ≤ 
0.05 (d). Data displayed as difference in labelling intensity between saline and LPS-injected eyes 
of the same animal.  
There was a relationship between iNOS and hypoxyprobe labelling in this model (Figure 
4.5.4.2.1.3 d). In the absence of a normal distribution (as assessed by the Shapiro-Wilk test, p ≤ 
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0.05) a non-parametric Spearman’s rank correlation coefficient revealed a significant relationship 
between iNOS and hypoxyprobe labelling (p ≤ 0.05). 
4.5.4.2.2. Electroretinogram characterisation 
ERG recordings collected 8 hours after intravitreal injections were influenced either by the 
preceding injection or by the repeated anaesthesia, as both the saline and the LPS-injected eyes had 
attenuated ERGs (Figure 4.5.4.2.2.1). It is possible that 8 hours was not sufficient for the subject to 
recover completely from anaesthesia or increased intraocular pressure caused by the injection. Even 
after 24 hours the ERG amplitude of the saline eye was attenuated. After 24 hours the ERG 
recording was sufficiently sensitive to measure a relative reduction in ERG amplitude in the LPS-
injected eye compared with the saline eye. Mice culled after 48 hours had almost indistinguishable 
ERGs in both eyes, while mice culled after 3 and 7 days show attenuated ERG amplitudes in LPS-
injected eyes (Figure 4.5.4.2.2.1). 
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Figure 4.5.4.2.2.1: ERG traces after intravitreal LPS/saline at different time points. 
(a) ERG traces of mice injected with 40ng of LPS into the vitreous of one eye and saline into the 
other, taken 8hrs, 24hrs, 48hrs, 3days and 7days post injection. (b) Difference in peak to peak 
difference between saline and LPS injected eyes sorted by day of culling, or by amount of 
inflammatory cell infiltration (as assessed by H&E labelling). All p ≥ 0.05 
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4.5.5. Systemic LPS 
Systemic inflammation was induced by an i.p. injection of LPS (1mg/kg, 3mg/kg, 5mg/kg). 
Mice showed a dose related clinical response ranging from mild sedation and decreased activity to 
somnolence, hunched appearance, piloerection and ocular discharge. They were culled 10 hours or 
24 hours after injection with LPS. 
4.5.5.1. (Immuno)histochemical characterisation  
Inflammation in the retina and spinal cord (data not shown) was assessed using microglial 
morphology (Figure 4.5.5.1.1) and iNOS labelling (data not shown). Overt inflammation was not 
detected in the spinal cord or retina after systemic injection of LPS using either of these markers. 
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Figure 4.5.5.1.1: Microglial activation and hypoxyprobe labelling in retinas after systemic 
LPS. 
Microglial activation (a) and (b) and hypoxyprobe labelling (c) and (d) in retinas of mice injected 
with LPS 10 hrs (a) and (c) or 24 hrs (b) and (d) prior. There is no microglial activation evident 
after systemic LPS injection and no relationship between LPS injection and hypoxyprobe 
labelling in the retina. All p ≥ 0.05. 
The slightly more activated morphology of microglia 10 hours as compared to 24 hours 
after saline and LPS injection (Figure 4.5.5.1.1 a and b) might be related to elevated stress levels 
shortly after handling and injection. 
4.5.6. Normal and transgenic (CFH-/-) ageing 
In order to investigate the effect of age and factor H deficiency on retinal hypoxia we 
injected four groups of mice with hypoxyprobe and compared the amount of labelling between 
these groups (see methods for details). Two groups consisted of wild type animals (5-6 weeks vs 
16-24 months) and two groups consisted of transgenic CFH-/- mice (4 weeks vs 14-15 months). 
There is no significant difference between hypoxyprobe labelling in old vs young wild type mice, 
while ageing in transgenic CFH-/- mice was associated with a significant increase in retinal 
hypoxyprobe labelling when compared with young CFH-/- mice (Figure 4.5.6.1) 
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Figure 4.5.6.1: Hypoxyprobe labelling in the retinas of old and young wild type and CFH-/- 
mice.  
(a) Example sections of old and young wild type C57bl/6 mice and CFH-/- mice. Scale bar = 
100µm. (b) Quantification of the intensity of hypoxyprobe labelled retinas (from ganglion cell 
layer to inner segment of photoreceptors). Data displayed as mean ± SEM. ** = p ≤ 0.01 
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4.5.7. Imaging flavoproteins in the retina 
It was possible to image the retina using confocal microscopy (Figure 4.5.7.1 and 4.5.7.2). 
The oxygen inspired by a yellow fluorescent protein (YFP) positive mouse (expressing YFP in a 
subset of ganglion cells) was varied from 100% to 0% oxygen. The change in oxygenation caused 
a change in background green fluorescence, assumed to arise from flavoprotein autofluorescence. 
The focal plane did not change, as revealed by the consistency of the YFP positive ganglion cell 
body and axons (Figure 4.5.7.1). 
 
Figure 4.5.7.1: Flavoprotein imaging in the retina of a YFP positive mouse.  
Mouse exposed to 100% O2 and 0% O2 (i.e. 100% nitrogen) reveals a change in the background 
green fluorescence. Scale bar is not determined as the optics of the eye do not allow accurate 
scale readings. 
To allow an increase in background signal strength, YFP negative mice were imaged and 
confirmed the reduction in the retinal flavoprotein signal with a reduction in inspired oxygen 
(Figure 4.5.7.2). 
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Figure 4.5.7.2: Example of flavoprotein signal in the naïve and hypoxaemic mouse retina. 
Quantification of flavoprotein signal with changes in inspired oxygen (a). Representative example 
images of flavoprotein signal in a mouse exposed to 100% and 5% inspired oxygen, and after death 
(b). Scale bar is not determined as the optics of the eye do not allow accurate scale readings. 
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4.6. Discussion 
Four experimental models were examined for potential use in a project to assess the 
relationship between inflammation and hypoxia in the retina (EAE, local LPS, systemic LPS and 
CFH-/-). We were able to demonstrate retinal inflammation in EAE and after intravitreal LPS 
injections and were able to show reduced amplitudes of the electroretinogram in these models. 
Furthermore, we found that the intravenous probe, hypoxyprobe, could indicate the presence of 
retinal hypoxia using the retinas of hypoxaemic mice as a positive control group. We were then 
able to assess hypoxyprobe labelling in the retina with inflammation during EAE, after intravitreal 
and systemic LPS injection and in transgenically aged CFH-/- knockout mice.  
4.6.1. Induction of retinal inflammation 
4.6.1.1. EAE 
The clinical disease course of EAE induced in female BN rats using rMOG is known to 
result in a lethal disease with a fast onset and progression (Stefferl et al. 1999). It is furthermore 
known to induce opticospinal inflammation, demyelination and ganglion cell loss (Collongues et 
al. 2012; Meyer et al. 2001) which mimics frequently observed optical damage in MS patients 
(Leibowitz and Alter 1968; Mcdonald and Barnes 1992; Sorensen et al. 1999) and in neuromyelitis 
optica (Collongues et al. 2012; Storch et al. 1998). Therefore, this model is known to involve 
inflammation and demyelination of the optic nerve combined with functional visual deficits. This 
is in agreement with our findings. We see functional deficit (as measured by ERG) following the 
onset of clinical symptoms and observe immune cell activation and infiltration in the optic nerves 
of EAE induced rats even before observable neurological deficits. However, the involvement of the 
retina has as yet not been well document.  
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Here we report that in rMOG induced EAE, microglial morphology showed a more 
activated phenotype in the spinal cord compared to the retina. However, while microglial 
morphological changes in the spinal cord coincided with clinical symptom onset (which is manifest 
in tail and hind limb weakness/paralysis), changes in the retina, despite being less severe, could be 
seen in asymptomatic as well as symptomatic animals. This reflects a very weak correlation 
between retinal and spinal cord inflammation. Interestingly, most microglial activation seems to be 
limited to the inner retina, observed predominantly in the ganglion cell layer, suggesting that retinal 
inflammation may originate mainly from optic nerve inflammation. Indeed high levels of 
phagocytic inflammation, as assessed by ED1 expression, were found in the optic nerve of 
symptomatic and, to a lesser extent asymptomatic animals, but this was not seen in the retina. This 
suggests the possibility of severe optic nerve inflammation leading to low level secondary 
microglial activation in the retina. Interestingly microglial activation in the retina and 
microglial/macrophage activation in the optic nerve seem to precede functional deficit as measured 
by ERG recordings and clinical score, and there is no relationship between the level of optic nerve 
inflammation (as assessed by ED1 positive cell coverage) and visual deficit (as measured by ERG). 
The ERG protocol was optimised to produce the strongest and most reliable signal. This 
includes dark adaptation for 1 hour and a stimulus intensity of 58mA with a stimulus interpulse 
period of 4 seconds. As shown in our experiments, this set-up was sufficient to distinguish 
pathological conditions from healthy vision. 
The initial negative ‘A’ wave of the ERG trace is believed to reflect photoreceptor and 
Muller glia cell function in the form of the ‘light current’, a decrease in the dark current after 
absorption of the light stimulus (Penn and Hagins 1969). The positive ‘B’ wave is believed to be 
largely related to ON-centre bipolar cells (Dong and Hare 2002; Green and Kapousta-Bruneau 
1999; Karwoski and Xu 1999) with contribution from amacrine cells and ganglion cells 
(Awatramani et al. 2001; Dong and Hare 2000; Dong and Hare 2002; Wurziger et al. 2001). It was 
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therefore not possible to localise the functional damage (as measured by ERG recordings) evident 
in our model to one retinal cell type, as both the ‘A’ and the ‘B’ wave component of the ERG are 
affected in rMOG induced EAE. The relative insensitivity of the ERG to localised changes in retinal 
function, due to the contribution of many layers towards the final trace, could explain the 
preservation of the ERG amplitude and latency in asymptomatic rats despite retinal and optic nerve 
inflammation. A more sensitive measure of, for example, ganglion cell function is the pattern ERG 
(Berardi et al. 1990) with alternating chequerboard patterns or sinusoidal gratings. This would be 
an interesting measure especially given the localisation of retinal inflammation to the inner retina 
in this model. 
Additionally, we found that the development of clinical symptoms is influenced by repeated 
ERG measurements, reducing the number of rodents reaching clinical signs by 50%. This is likely 
to be related to the complex orchestra of hormones and cytokines released when an organism is 
stressed, e.g. following repeated anaesthetic episodes, which can include the release of anti-
inflammatory steroids (Desborough 2000; Joels and Baram 2009). 
4.6.1.2. Local LPS 
As a component of Gram-negative bacteria, LPS can initiate an inflammatory reaction upon 
injection. To achieve retinal inflammation we injected mice with various concentrations of LPS 
into the vitreous of one eye (saline into the control eye) and culled them at different time points 
thereafter. The interpretation of the results was made more difficult by a large variation in the level 
of inflammation in the retinas of different subjects and the possibility of light physical damage to 
the retina, combined with LPS, resulting in complete retinal disorganisation and haemorrhage. 
Possibly as a result of inter-individual variation there was no demonstrable relationship between 
days post-injection and the level of inflammation.  
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It was possible to see a change in the morphology of microglia towards an 
activated/amoeboid phenotype following intravitreal LPS injections. Even in situations in which 
there was no obvious infiltration of inflammatory cells, activation of microglia was still present, 
confirming that the innate immune system provides the first line of defence in situ. Already 8 hours 
after an LPS injection microglial activation was evident, even without concomitant inflammatory 
cell infiltration. It was also evident that iNOS was upregulated in retinas during severe inflammation 
but was similar to saline injected counterparts in the absence of inflammatory cell infiltration or 
when infiltration was only mild.  
ERG recordings, following intravitreal LPS injections, were effective in distinguishing 
retinas with severe inflammation from retinas with no inflammation, while mild or moderate 
inflammation did not consistently lead to reductions in ERG amplitude. However, ERG recordings 
were complicated by the effect of the intravitreal injection. It is possible that the anaesthetic used 
during the LPS injection or the increase in intraocular pressure reduced the ERG amplitude 
significantly at 8 hours and even 24 hours post intravitreal injection in saline and LPS injected 
animals. This attenuation of the healthy signal can influence the sensitivity of the ERG towards 
functional alterations with inflammation. Additionally post mortem histology revealed 
haemorrhage in cases with severe retinal inflammation. This, together with optical clouding from 
cellular infiltrates, could prevent light penetration to the retina and reduce the amplitude of the ERG 
traces without appropriate functional underpinnings. These factors taken together suggest that 
ERGs are not a good readout of retinal function after intavitreal injections of pro-inflammatory 
components. 
4.6.1.3. Systemic LPS 
Given the problems associated with the reproducibility and functional assessment of retinal 
inflammation induced by intravitreal LPS injections we decided to induce systemic inflammation 
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to assess the level of resulting retinal inflammation. Unfortunately systemic injections of all the 
concentrations assessed here (1mg/kg, 3mg/kg and 5mg/kg), despite resulting in a dose dependent 
increase in clinical signs, including ocular discharge and lethargy, did not result in any retinal 
inflammation. This is not in agreement with previous findings which suggested that systemic 
injections of LPS in the same strain of rodent can lead to retinal inflammation and damage as 
assessed by oxidative stress (Kubota et al. 2009; Sasaki et al. 2009), increased levels of IL-6 and 
iNOS mRNA (Nagai et al. 2005), leukocyte adhesion (Kubota et al. 2009; Nagai et al. 2005), 
astrocyte activation (Kurihara et al. 2006), reduction in retinal proteins (Kurihara et al. 2006), outer 
segment shortening (Sasaki et al. 2009) and function deficits (Kurihara et al. 2006; Sasaki et al. 
2009). One possible explanation is that most studies used higher doses of LPS though some were 
only marginally higher (e.g. 6mg/kg (Kurihara et al. 2006)). Another possibility is that the previous 
studies used more sensitive techniques to assess retinal inflammation, including reverse 
transcription polymerase chain reaction enzyme-linked immunosorbent assay.  
4.6.2. Hypoxia and retinal inflammation 
The retina is believed to be one of the most metabolically active tissues in the body with 
photoreceptors consuming more oxygen than any other cell in the body (Arden et al. 2005; Hughes 
et al. 2010). Together with a relative avascularity this leads to a low oxygen tension in the retina 
under normal conditions (de Gooyer et al. 2006). This low oxygen concentration in the retina, has 
been suggested to be relevant in a range of visual diseases, including age-related macular 
degeneration and diabetic retinopathy (Arden et al. 2005; Lahdenranta et al. 2001). Hypoxia 
therefore, warrants a close investigation and characterisation in normal as well as pathological 
retinas and a histochemical investigation of hypoxia is of particular benefit as it has the potential to 
determine the distribution of hypoxic areas as well as their spatial and temporal correlates.  
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The intravenous probe, hypoxyprobe, thanks to its ability to penetrate easily into tissues 
and its relative safety and specificity (Lee et al. 2014), lends itself to the immunohistochemical 
study of hypoxia in the retina. We confirmed the applicability of hypoxyprobe to label retinal 
hypoxia by varying the atmospheric oxygen concentration that naïve mice were exposed to and 
quantifying the resulting change in DAB labelling in their retinas: A 50% decrease in environmental 
oxygen for 4 hours is sufficient to increase hypoxyprobe labelling in the retina. Results from this 
hypoxaemia study are in line with previous evidence suggesting that the inner plexiform layer is 
highly metabolically active and yet avascular (Yu and Cringle 2001). This putative disconnection 
between oxygen demand and supply would predict vulnerability towards hypoxaemia and is 
reflected in high levels of hypoxyprobe labelling in the inner plexiform layers of hypoxaemic mice. 
We also find increases in hypoxyprobe labelling in the inner segment (of photoreceptors) of mice 
subjected to hypoxaemia, as expected from this highly metabolic layer located in an avascular 
region (Figure 4.1.1.1 b (Yu and Cringle 2001)), although this finding is not as consistent as 
expected. Such a discrepancy might be related to the need for dark adaptation and the dark current 
to reach the full metabolic potential of the inner segment of the photoreceptors (Wangsa-Wirawan 
and Linsenmeier 2003). Additionally previous work also suggests that the nuclear layers as well as 
the outer segment are not highly metabolically active (Yu and Cringle 2001) which is in agreement 
with an absence of positive hypoxyprobe labelling in these layers, even during hypoxaemia. 
However, our work diverges from previous investigators who suggested that the inner retina is less 
prone to changes in oxygenation, compared to the outer retina, due to the adaptability of the retinal 
vasculature in contrast to the inflexible choroidal vasculature (Wangsa-Wirawan and Linsenmeier 
2003). Instead, we find that hypoxaemia affects mainly the inner retina. This inconsistency with 
previous suggestions may be because the level of hypoxaemia was sufficiently high and prolonged 
to prevent the compensatory mechanisms offered by the retinal vasculature, or may be related to 
species differences. 
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Our results also suggest that after 1 hour there may be residual hypoxyprobe in the tissue 
causing spurious labelling in mice subjected to room air. Indeed the half-life of hypoxyprobe in 
mice is 25 minutes (Lee et al. 2014) suggesting that after 50 minutes there is approximately ¼ of 
the original amount in the blood of the animal. When tissue is harvested any residual amounts of 
hypoxyprobe may bind under the hypoxic conditions created during perfusion. 
Having established hypoxyprobe as a marker of hypoxia in the retina we then explored the 
relationship between inflammation and hypoxia in the retina. Indeed, we found that retinas of eyes 
injected with LPS (into the vitreous) labelled significantly more strongly for hypoxyprobe, if 
inflammation was present (as assessed by inflammatory cell infiltration) as compared with their 
saline injected counterparts. Indeed, a positive correlation between retinal iNOS labelling (a marker 
of inflammation) and retinal hypoxyprobe labelling was revealed, following intravitreal LPS 
injection. In contrast we found only a very mild, non-significant relationship between the clinical 
presentation of EAE and hypoxyprobe labelling. Additionally, in the absence of retinal 
inflammation, during systemic endotoxemia, we found no increase in hypoxyprobe labelling. These 
findings strongly suggest that hypoxyprobe labelling is only robustly increased during high levels 
of inflammation.  
While normally aged retinas were not significantly different from young retinas, enhanced 
hypoxyprobe labelling was observed in the aged CFH-/- retinas. This is in line with reports 
suggesting an essential role for complement factor H in the maintenance of retinal perfusion in age 
(von Leithner et al. 2009). Here the authors found significant deposits of the C3 and C3b 
complement components along retinal vessels and Bruch’s membrane of aged knockout mice (von 
Leithner et al. 2009). Furthermore, C3b deposition was associated with vascular constrictions (von 
Leithner et al. 2009), suggesting a detrimental effect on local perfusion. Overall, there was a 
reduction in vessel density in aged CFH-/- mice together with a withering of the remaining network. 
Additionally perfusion rates, as assessed by fluorescein uptake and clearance, were reduced in aged 
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knockout mice and compromised perfusion was confirmed through reduced leakage of intravenous 
dextra (von Leithner et al. 2009) following laser lesions (von Leithner et al. 2009). These findings 
provide a reasonable explanation for enhanced hypoxyprobe labelling only in aged CFH-/- as 
vascular changes, indicative of hypoperfusion, were only evident in transgenic mice with aged wild 
type mice showing no obvious abnormalities. This has potential implications for age-related 
macular degeneration in which nucleotide substitutions of the CFH gene are common (Coffey et al. 
2007; von Leithner et al. 2009). However, it should be noted that the CFH deficient mouse model 
only reflects some of the characteristic changes seen in human AMD with one of the major 
differences being reduced plasma C3 concentration in knockout mice, with preserved levels in 
human patients. 
Inflammation could lead to hypoxia due to the increased energetic demand of an 
inflammatory environment (Eltzschig and Carmeliet 2011), which may include hypercellularity or 
increased use of oxygen for non-energetic needs, like free radical production. Additionally, 
inflammation may decrease the supply of oxygen via thrombosis or compression (Eltzschig and 
Carmeliet 2011) as well as leading to endothelial cell and vascular damage (von Leithner et al. 
2009). Such factors may be particularly relevant in the eye where the blood supply is 
physiologically limited due to the need for clear optics (Yu and Cringle 2001). 
4.6.3. In vivo retinal imaging 
The assessment of the retina, even in humans, using confocal microscopy, has seen huge advances in 
recent years with the development and use of the (confocal) scanning laser ophthalmoscope (Helb et 
al. 2010; Wollstein et al. 1998). These advances also include the use of retinal autofluorescence, for 
example in the investigation of geographic atrophy in AMD (Holz et al. 2001). In the current work 
we have assessed the use of flavoprotein autofluorescence for the visualization of mitochondrial 
function in retinal inflammation. 
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It was possible to image the back of the eye, using standard confocal microscopy. The 
method was initially developed using transgenic mice expressing YFP in a subset of retinal ganglion 
cells. It was possible to show reductions in background green autofluorescence (also replicated in 
YFP negative mice) with a decrease in inspired oxygen, which, as in the cortex, was reversible upon 
re-oxygenation. However, it is also clear that the ratio of flavoprotein fluorescence (oxygen 
sensitive fluorescence) to other green autofluorescence (insensitive to change in inspired oxygen) 
in the retina is not as substantial as in the brain. This finding is in line with the high lipofuscin and 
melanin content in the retina (Bindewald et al. 2004; Wabbels et al. 2006). Lipofuscin, in particular, 
accumulates in the retinal pigment epithelium as a result of photoreceptor outer segment 
phagocytosis, and fluoresces strongly in the same wavelengths as flavoproteins (Bindewald et al. 
2004; Delori et al. 1995; Wabbels et al. 2006). The relatively low signal (flavoprotein fluorescence) 
to noise (other green fluorescence) ratio, may prove particularly detrimental when assessing 
mitochondrial redox potential in conditions that could change the optics of the eye, including 
inflammation and ageing, which may reduce the signal to noise ratio even further. Therefore, 
longitudinal interventions and assessment may be necessary, including for example changes in 
retinal flavoprotein signal in response to hypoxaemia, but may limit the possible study designs 
applicable to retinal flavoprotein imaging.  
153 
 
4.7. Limitations and further research 
It is evident that the induction of reliable and reproducible levels of retinal inflammation 
has encountered some problems. Local injection of endotoxin has provided the highest level of 
retinal inflammation but it was frequently concomitant with haemorrhage and other complications, 
leading to problems with ERG recordings and in vivo retinal imaging, resulting from optical 
clouding and the obstruction of light as well as possible alterations of aqueous fluid dynamics 
(Forrester 1991). 
The effects of systemic LPS seem not to cross the blood retinal barrier effectively, thereby 
preventing the induction of retinal inflammation, at least with our detection methods. Instead, 
systemic endotoxemia may be more effective in inducing retinal inflammation when the blood 
retinal barrier is damaged, by for example co-injecting agents that can induce blood brain/retinal 
barrier breakdown (Argaw et al. 2009; Azmin et al. 1985; Saija et al. 1997). However, it should be 
noted that these agents may have effects outside the blood brain barrier which should be considered 
before administration. Blood brain/retinal barrier weakening also occurs in ageing (Chan-Ling et 
al. 2007; Hughes et al. 2006; Popescu et al. 2009) and could provide a feasible alternative for the 
induction of retinal inflammation using systemic injections of endotoxins. However, again several 
other factors change with ageing which need to be evaluated in the experimental design.  
The use of an autoimmune disease model to study retinal inflammation has shown some 
promise by providing reproducible but very mild levels of retinal inflammation. This is likely to be 
related to the use of a myelin antigen which resulted in strong optic nerve inflammation (where 
myelin is abundant) with possibly secondary retinal inflammation. This could be counteracted by 
using a retinal antigen (for example interphotoreceptor binding protein (Fox et al. 1987), S-antigen 
(Dekozak et al. 1981), or rhodopsin (Schalken et al. 1988)) to induce experimental autoimmune 
uveitis. 
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In conditions in which strong retinal inflammation was induced we were also able to show 
an increase in hypoxyprobe labelling, suggesting a relationship between hypoxia and inflammation. 
However, it should be noted that to make firm conclusions on the relationship between hypoxia and 
inflammation other markers of hypoxia should be used, including the use of invasive oxygen probes. 
Nevertheless, we have gone one step further in assessing this relationship by replicating a finding 
from spinal cord inflammation, which has been validated using intraspinal oxygen probe measures 
(Davies et al. 2013), in the retina using different inflammatory insults. What we have not replicated 
however, is the relationship between hypoxia and functional deficits. A future project based on the 
therapeutic use of oxygen during retinal inflammation is necessary to comment on the causal role 
played by hypoxia in retina dysfunction during inflammation.  
4.8. Conclusion 
We find that retinal inflammation can be induced by inravitreal injections of LPS and, to a 
lesser extent, by immunisation with a MOG antigen. Such inflammation can lead to a corresponding 
decrease in ERG amplitude which however is complicated during severe retinal inflammation by 
possible haemorrhage and ocular opacity due to inflammatory cell infiltrates. Additionally, high 
levels of inflammation as well as transgenic CFH-/- ageing led to an increase in hypoxyprobe 
labelling which suggests the presence of hypoxia. Finally, we showed that it is possible to assess 
mitochondrial flavoprotein fluorescence in the naïve mouse retina, using standard confocal 
microscopy. 
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CHAPTER FIVE 
5. Final discussion and clinical 
relevance 
The work presented in this thesis provides evidence that certain types of inflammatory 
conditions can be associated with low oxygen levels in CNS organs and that this can have 
implications for mitochondrial function. Additionally, we show that it is possible to assess 
mitochondrial redox state in vivo with high spatial and temporal resolution in both the brain and the 
retina.   
Following the observation that systemic inflammation can lead to cerebral hypoxia and 
resulting increases in mitochondrial vulnerability to hypoxaemia (as assessed by changes in 
flavoprotein fluorescence) we report an investigation of several models of retinal inflammation, 
assessing their reliability, their level of inflammation, and their applicability to confocal assessment 
of retinal flavoproteins. Overall the attempt to find a reliable model of retinal inflammation that 
would allow longitudinal assessment of changes in flavoprotein fluorescence was problematic as 
only very high levels of inflammation, or an aged transgenically induced model of AMD, led to 
tissue hypoxia (as assessed by hypoxyprobe labelling). These very high levels of inflammation and 
aged transgenic AMD models are not conducive to longitudinal assessment of flavoprotein 
fluorescence as the optical clouding associated with high level ocular inflammation and ageing can 
obscure clear vision of the retina. This does not however prevent the assessment of the differential 
vulnerability of mitochondria to additional insults (e.g. hypoxaemia) during inflammation. 
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There are two main reasons why considerable effort has been invested in the use of 
flavoprotein assessment during retinal inflammation. First of all the retina is highly sensitive to 
reductions in oxygen, given the necessarily limited nature of the retinal vasculature (constrained 
due to the need for clear optics (Yu and Cringle 2001)), combined with a high metabolic activity 
(Ames 1992; Anderson 1968; Toernquist and Alm 1979; Wangsa-Wirawan and Linsenmeier 2003). 
Indeed, as shown in chapter 4 parts of the retina (including the highly metabolically active inner 
segment of the photoreceptors (Yu and Cringle 2001)) are located in avascular regions. Therefore 
the consequences associated with inflammation-induced hypoxia would be predicted to have an 
even greater impact on the retina in comparison with more vascularised tissues. Secondly, the retina 
which has been considered as a ‘window on the brain’ (Cordeiro et al. 2004), provides significant 
clinical potential. It is the only CNS organ that can be visualised non-invasively giving potential 
for use in the clinic in which (confocal) scanning laser ophthalmoscopes are already in regular use 
(Helb et al. 2010; Wollstein et al. 1998). By determining correction factors for ocular clouding or 
by using longitudinal designs which include the introduction of additional insults (e.g. hypoxaemia) 
and assessing the response of the flavoprotein signal to these insults, it might still be possible to 
explore the use of flavoprotein fluorescence in human subjects. 
Additionally, our findings on systemic inflammation and cortical hypoxia together with 
their implications on mitochondrial function provide clinically relevant information. We report that 
increased mitochondrial vulnerability towards hypoxaemia during systemic endotoxemia (as 
assessed by changes in flavoprotein fluorescence) can be attenuated by energy conserving 
treatments (such as hypothermia). Despite the limitations of the model used (described in chapter 
2) these findings suggest that such treatments may provide potential in the clinical setting. As 
mentioned in the introduction (chapter 1) a clinical trial on L-NMMA (a nitric oxide synthase 
inhibitor) had to be terminated prematurely due to a higher mortality rate in the treatment group 
(Grover et al. 1999). Given that inhibition of NOS can lead to enhanced metabolism and oxygen 
157 
 
consumption, (Laycock et al. 1998; Shen et al. 1994) the failure of the trial could be explained using 
the results from this thesis which suggest that an increase in mitochondrial oxygen consumption 
(e.g. through induced normothermia or L-NMMA administration) may be detrimental during 
systemic inflammation and sepsis. Therefore, treatments which enhance organ perfusion, such as 
nitroglycerine (Spronk et al. 2002), together with mild inhibitors of metabolism, might restore the 
energetic imbalances reported in sepsis by us and others, e.g. (Balestra et al. 2009), and so provide 
patients the energetic capacity to survive and recover.  
5.1. Future directions 
The data reported here show that inflammation can cause tissue hypoxia in different organs, 
including the brain, during systemic inflammation, and in the retina during local intravitreal 
inflammation and inflammation-enhanced ageing. Furthermore the data reported here also link this 
inflammatory hypoxia with mitochondrial dysfunction in the cerebral cortex of endotoxic mice. 
However, several questions were not answered: 
1) Does the inflammation-associated hypoxia originate from a compromised supply of 
oxygen, or from an excessive demand? To explore this question it would be 
interesting to investigate whether vascular dysfunction, including endothelial cell 
dysfunction, impaired red blood cell deformability, hypovolaemia and/or 
microcirculatory heterogeneity, increase the presence of hypoxic foci in the CNS 
during inflammation. Equally, enhanced oxygen demand may play a role in the 
presence of hypoxia, which could be related to an increase in metabolic rate, 
mitochondrial uncoupling, hypercellularity and/or increased consumption of oxygen 
for the production of reactive oxygen and reactive nitrogen species. 
2) Although hypothermia was protective against the enhanced vulnerability of cortical 
mitochondria during systemic inflammation, the mechanism by which protection was 
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achieved has not been explored. There are multiple ways in which hypothermia may 
be protective in this model, including enhanced oxygenation of the hypoxic tissue by 
reducing metabolic demand for oxygen, or increasing blood flow. Additionally, 
hypothermia is known to suppress the immune system thereby potentially reducing 
immune-mediated damage.  
3) Although hypoxia was assessed during inflammatory conditions both in the retina 
and the cortex through the use of hypoxyprobe labelling and oxygen probe 
measurements respectively, we did not specify the cell types exhibiting hypoxia 
(although a previous study associating spinal cord inflammation with hypoxia 
suggested global tissue hypoxia (Davies et al. 2013)), or which cell types are 
particularly vulnerable to hypoxia. It is known that glial cells are capable of 
generating ATP via glycolysis (Funfschilling et al. 2012; Pellerin and Magistretti 
1994; Voloboueva et al. 2013) while neurons rely primarily on oxidative metabolism 
(Almeida et al. 2001; Belanger et al. 2011; Herrero-Mendez et al. 2009), which would 
place them in a potentially more vulnerable position. 
4) As mentioned above, the clinical applications of the described work should be 
explored in more detail. This includes both the administration of hypothermia (or 
other energy conserving therapies in different models of sepsis) as well as the use of 
retinal flavoprotein imaging as a window on the energetics of the brain. 
5.2. Conclusion 
Overall, this thesis aimed to explore the possibility of flavoprotein imaging in the cerebral 
cortex and retina of anaesthetised mice, and to investigate the relationship between mitochondrial 
function, tissue oxygen and inflammation in these two CNS organs. The findings reveal that it is 
possible to use flavoprotein fluorescence to indicate mitochondrial redox potential in vivo in both 
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the brain and the retina. Using this technique, as well as other established methods, we have shown 
a relationship between systemic inflammation and cortical hypoxia, and the functional 
consequences with regard to mitochondrial vulnerability towards additional energetic insults such 
as hypoxaemia. We hypothesized that the enhanced sensitivity (both in terms of mitochondrial 
flavoprotein fluorescence and survival) was related to energetic dysfunction due to an imbalance 
between oxygen demand and supply. We further explored the hypothesis regarding an energetic 
imbalance by showing that hypothermia, known to decrease metabolic demand in a response 
suggestive of hibernation (Protti and Singer 2006), attenuated increased mitochondrial vulnerability 
towards hypoxaemia. 
Having established this functionally relevant relationship between inflammation, hypoxia 
and mitochondrial function we wanted to explore the link between inflammation and hypoxia in 
another CNS organ, the retina. This investigation was combined with an attempt at assessing 
mitochondrial redox state (through flavoprotein fluorescence) in the retina in vivo in order to 
develop a ‘window’ to the inflamed brain with an aim at clinical applicability. However, the level 
of retinal inflammation achieved in our experiments was relatively binary, with very mild 
inflammation, primarily limited to the retinal-vitreal interface, or complete retinal disorganisation 
(including haemorrhage), being the predominant outcomes. In the case of very mild inflammation, 
hypoxia was not readily evident (as assessed by hypoxyprobe labelling), while higher levels of 
inflammation were not very encouraging for the purpose of in vivo imaging, as optical clouding 
would confound absolute measurements of flavoprotein fluorescence. However, as with cortical 
flavoprotein imaging it may be possible to utilize experimental designs with longitudinal 
manipulations which would allow for normalised readouts. 
Our findings provide insight into the consequences of sepsis and systemic/CNS 
inflammation, and reveal an opportunity for therapies based on the correction of energetic 
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deficiencies reported in some inflammatory conditions. The observations also establish a tool for 
the investigation of mitochondrial function in both the brain and the retina. 
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